Pre-eclampsia or poor fetal growth

O15_PREEC_OR_FETGRO

No definition available.

Endpoint definition

↥

Endpoint definition steps	FinnGen
Phenotype data	520210
1. Apply sex-specific rule only females	293373
2. Check conditions None	293373
3. Check pre-conditions, main-only, mode, registry filters Registry filters: Hospital discharge: ICD-10 — O36.5 Hospital discharge: ICD-9 — 6565A\|6565B Cause of death: ICD-10 — O36.5 Cause of death: ICD-9 — 6565A\|6565B 2 out of 7 registries used, show all original rules.	5571
4. Check minimum number of events None	5571
5. Include endpoints O15_PRE_OR_ECLAMPSIA	14828
6. Filter based on genotype QC (FinnGen only)	14828

Control definitions (FinnGen only)

Controls for this endpoint are individuals that are not cases.

Extra metadata

First used in FinnGen datafreeze: DF7

NAME	O15_PREEC_OR_FETGRO
CONTROL_EXCLUDE
CONTROL_PRECONDITIONS
CONTROL_CONDITIONS
SEX	2
INCLUDE	O15_PRE_OR_ECLAMPSIA
PRE_CONDITIONS
CONDITIONS
OUTPAT_ICD
OUTPAT_OPER
HD_MAINONLY
HD_ICD_10_ATC
HD_ICD_10	O365
HD_ICD_9	6565A\|6565B
HD_ICD_8	$!$	The FinnGen clinical team has checked and no code can be used for this rule.
HD_ICD_10_EXCL
HD_ICD_9_EXCL
HD_ICD_8_EXCL
COD_MAINONLY
COD_ICD_10	O365
COD_ICD_9	6565A\|6565B
COD_ICD_8	$!$	The FinnGen clinical team has checked and no code can be used for this rule.
COD_ICD_10_EXCL
COD_ICD_9_EXCL
COD_ICD_8_EXCL
OPER_NOM
OPER_HL
OPER_HP1
OPER_HP2
KELA_REIMB
KELA_REIMB_ICD
KELA_ATC_NEEDOTHER
KELA_ATC
KELA_VNRO_NEEDOTHER
KELA_VNRO
CANC_TOPO
CANC_TOPO_EXCL
CANC_MORPH
CANC_MORPH_EXCL
CANC_BEHAV

Similar endpoints

↥

List of similar endpoints to Pre-eclampsia or poor fetal growth based on the number of shared cases.

Similar with more cases:

Similar with less cases:

Case counts by codes

↥

FinnGen case counts by registry codes:

Upset plot

Full data table

Summary Statistics

↥

-FinRegistry-

Key figures

	All	Female	Male
Number of individuals
Whole population	106315	106315	-
Only index persons	104055	104055	-
Unadjusted period prevalence (%)
Whole population	3.05	3.05	-
Only index persons	3.83	3.83	-
Median age at first event (years)
Whole population	-	28.82	-
Only index persons	-	28.80	-

-FinnGen-

Key figures

	All	Female	Male
Number of individuals	14828	14828	-
Unadjusted period prevalence (%)	5.05	5.05	-
Median age at first event (years)	29.09	29.09	-

-FinRegistry-

Age distribution of first events

-FinnGen-

Age distribution of first events

-FinRegistry-

Year distribution of first events

-FinnGen-

Year distribution of first events

-FinRegistry-

Cumulative Incidence Function

-FinnGen-

Cumulative Incidence Function

CodeWAS (R11)

↥

CodeWAS is a tool for exploring the associations between an endpoint and all of the medical codes and drug codes.

This is a new tool, please reach out using the contact form for feedback and improvement ideas.

First, a cohort is built by matching controls to the endpoint cases using year of birth and sex. Then, a Fisher test is done for all the medical codes and drug codes between the cases and controls of this cohort. Codes are reported in the table below if they have −log₁₀(p-value) ≥ 6.

Matched cohort

Matched cases
13279: Matched controls
132370

Code

Vocabulary

Description

Odds Ratio

-log₁₀(p)

N matched cases

N matched controls

Z35.8

ICD-10 Finland

Supervision of other high-risk pregnancies

2.9

323.0

2872

11476

63703

ICD-8 Finland

Pre-eclampsia, eclampsia and toxaemia, unspecified, Prae-eclampsia levis

+∞

323.0

1975

O36.5

ICD-10 Finland

Maternal care for poor fetal growth

3126.7

323.0

4193

C07AG01

ATC

labetalol; systemic

12.0

323.0

705

615

MA2AE

NOMESCO Finland

Ultrasound examination of pregnancy (at 12. week of gestaion or later) including basic examination of fetus

2.3

323.0

4270

22492

6425A

ICD-9 Finland

Hypertension complicating pregnancy, childbirth and the puerperium, Severe pre-eclampsia[PRAE-ECLAMPSIA GRAVIS, ENNEN SYNNYTYSTÄ]

+∞

323.0

311

O13

ICD-10 Finland

Gestational [pregnancy-induced] hypertension

7.9

323.0

2662

4083

O14.1

ICD-10 Finland

Severe pre-eclampsia

10792.1

323.0

1012

O14.0

ICD-10 Finland

Mild to moderate pre-eclampsia

9884.9

323.0

2468

6565A

ICD-9 Finland

Other foetal and placental problems affecting management of mother, Poor foetal growth[SIKIÖN HIDASTUNUT INTRAUTERIININ KASVU,RASK AIK]

+∞

323.0

449

6424B

ICD-9 Finland

Hypertension complicating pregnancy, childbirth and the puerperium, Mild or unspecified pre-eclampsia[PRAE-ECLAMPSIA LEVIS, SYNNYTYKSEN AIKANA]

+∞

323.0

351

O14.9

ICD-10 Finland

Pre-eclampsia, unspecified

788.8

323.0

1727

6424A

ICD-9 Finland

Hypertension complicating pregnancy, childbirth and the puerperium, Mild or unspecified pre-eclampsia[PRAE-ECLAMPSIA LEVIS, ENNEN SYNNYTYSTÄ]

+∞

323.0

1258

MCA10

NOMESCO Finland

Lower uterine segment caesarean section

3.1

323.0

3507

13771

63704

ICD-8 Finland

Pre-eclampsia, eclampsia and toxaemia, unspecified, Prae-eclampsia gravis

+∞

323.0

426

MA2DE

NOMESCO Finland

Detailed ultrasound examination of fetus including color doppler method

3.1

323.0

2843

10800

O10.0

ICD-10 Finland

Pre-existing essential hypertension complicating pregnancy, childbirth and the puerperium

7.1

314.1

811

1196

O82.10

ICD-10 Finland

Delivery by emergency caesarean section

3.1

309.3

1911

6751

6565B

ICD-9 Finland

Other foetal and placental problems affecting management of mother, Poor foetal growth[SIKIÖN HIDASTUNUT INTRAUTERIININ KASVU,SYNN AIK]

+∞

272.5

261

66120

ICD-8 Finland

Occipital presentation

+∞

254.7

244

O34.2

ICD-10 Finland

Maternal care due to uterine scar from previous surgery

2.8

236.3

1764

6962

MA2HE

NOMESCO Finland

Detailed morfological ultrasound examination of fetus

2.0

235.4

4031

23774

6425B

ICD-9 Finland

Hypertension complicating pregnancy, childbirth and the puerperium, Severe pre-eclampsia[PRAE-ECLAMPSIA GRAVIS, SYNNYTYKSEN AIKANA]

+∞

225.4

216

205

Kela drug reimbursment

Chronic hypertension

2.5

224.8

2018

8834

Z36.3

ICD-10 Finland

Antenatal screening for malformations using ultrasound and other physical methods

1.8

220.9

5521

37087

8811

FHL

Cesarean section

3.0

216.6

1395

4993

Z39.2

ICD-10 Finland

Routine postpartum follow-up

2.0

211.5

3428

19627

O11

ICD-10 Finland

Pre-eclampsia superimposed on chronic hypertension

985.2

199.2

195

SPAT1379

SPAT

Health check-up of pregnant person

2.0

189.7

2926

16309

ZXD05

NOMESCO Finland

Urgent procedure

1.8

189.2

4571

29915

I10

ICD-10 Finland

Essential (primary) hypertension

1.8

188.1

4708

31146

63710

ICD-8 Finland

Pre-eclampsia, eclampsia and toxaemia, unspecified, Eclampsia

+∞

187.7

180

W84

ICPC

Pregnancy high risk

3.0

171.7

1082

3790

63799

ICD-8 Finland

Pre-eclampsia, eclampsia and toxaemia, unspecified, Toxaemia, unspecified

+∞

168.9

162

O60

ICD-10 Finland

Preterm labour and delivery

3.5

163.1

825

2458

O24.4

ICD-10 Finland

Diabetes mellitus arising in pregnancy

2.1

160.8

2181

11442

O41.0

ICD-10 Finland

Oligohydramnios

4.1

159.4

666

1686

O80.8

ICD-10 Finland

Other single spontaneous delivery

2.6

158.1

1255

5064

SPAT1197

SPAT

Extensive health check-up of expecting family

1.8

155.7

3206

19628

XMA22

NOMESCO Finland

General examination of pregnant woman

2.3

153.0

1561

7188

MAC10

NOMESCO Finland

Antepartum dilatation of cervical canal

3.5

150.5

747

2190

W78

ICPC

Pregnancy

1.8

150.1

3522

22451

O47.0

ICD-10 Finland

False labour before 37 completed weeks of gestation

2.0

144.6

2170

11806

SPAT1380

SPAT

Postpartum check-up

1.9

139.9

2411

13797

6423A

ICD-9 Finland

Hypertension complicating pregnancy, childbirth and the puerperium, Transient hypertension of pregnancy[HYPERTENSIO GRAVIDARUM, ENNEN SYNNYTYSTÄ]

6.5

134.9

366

572

C08CA05

ATC

nifedipine; systemic

3.2

133.0

766

2508

C09AA02

ATC

enalapril; systemic

2.2

132.2

1503

7251

Z32.1

ICD-10 Finland

Pregnancy confirmed

1.9

130.0

2377

13847

Z35.2

ICD-10 Finland

Supervision of pregnancy with other poor reproductive or obstetric history

3.6

126.5

620

1795

O68.0

ICD-10 Finland

Labour and delivery complicated by fetal heart rate anomaly

2.3

120.9

1254

5783

MA2XE

NOMESCO Finland

Other obstetric ultrasound examination

2.0

119.6

1630

8478

63701

ICD-8 Finland

Pre-eclampsia, eclampsia and toxaemia, unspecified, Hypertonia

5.3

118.4

377

720

MAA00

NOMESCO Finland

Amniocentesis

3.1

110.8

650

2151

O82.0

ICD-10 Finland

Delivery by elective caesarean section

2.3

109.0

1151

5340

Z35.9

ICD-10 Finland

Supervision of high-risk pregnancy, unspecified

2.6

108.3

873

3524

103

Kela drug reimbursment

Diabetes, insulin-treated

1.8

107.5

2001

11647

O24.0

ICD-10 Finland

Diabetes mellitus in pregnancy: Pre-existing diabetes mellitus, insulin-dependent

3.6

106.7

508

1435

215

Kela drug reimbursment

Diabetes, non-insulin-treated

1.8

105.5

1969

11464

A10AC01

ATC

insulin (human); parenteral (insulins and analog. for injection, intermediate-acting)

2.5

105.4

890

3685

O12.1

ICD-10 Finland

Gestational proteinuria

7.2

104.6

264

373

MAC96

NOMESCO Finland

Other induction or advancement of labour

2.8

104.1

720

2653

C08CA01

ATC

amlodipine; oral

1.7

96.8

2460

15718

Z87.5

ICD-10 Finland

Personal history of complications of pregnancy, childbirth and the puerperium

4.7

93.7

331

709

O30.0

ICD-10 Finland

Twin pregnancy

3.3

93.1

490

1497

SPAT1196

SPAT

Monitoring of normal pregnancy

1.8

90.9

1690

9781

MA1AE

NOMESCO Finland

Ultrasound examination of early pregnancy (before 12. postmenstrual week)

1.7

89.6

2294

14650

WX320

NOMESCO Finland

Spinalanesthesy

1.6

89.5

2570

16942

SPAT1317

SPAT

Planned health check-up monitoring, health check-up performed based on individual need

1.7

89.4

2065

12795

C07AB02

ATC

metoprolol; systemic

1.8

85.2

1584

9155

SPAT1262

SPAT

Handing over of treatment supplies

1.8

85.1

1605

9319

A10BA02

ATC

metformin; oral

1.7

81.5

2076

13201

Z34.8

ICD-10 Finland

Supervision of other normal pregnancy

1.5

80.3

3117

22057

O32.1

ICD-10 Finland

Maternal care for breech presentation

2.0

76.9

1012

5137

Z36.0

ICD-10 Finland

Antenatal screening for chromosomal anomalies

1.9

76.6

1162

6238

MAC01

NOMESCO Finland

Rupture of aminiotic membrane for induction of labor

2.9

75.0

480

1680

Z34.9

ICD-10 Finland

Supervision of normal pregnancy, unspecified

1.6

74.9

2334

15621

A10AE04

ATC

insulin glargine; parenteral

2.2

73.1

802

3763

63709

ICD-8 Finland

Pre-eclampsia, eclampsia and toxaemia, unspecified, Prae-eclampsia NUD

+∞

72.9

A10AB05

ATC

insulin aspart; parenteral (insulins and analog. for injection, fast-acting)

2.3

72.8

722

3230

SPAT1263

SPAT

Sampling

1.4

70.1

5266

42287

E66.01

ICD-10 Finland

Obesity due to excess calories

1.8

70.1

1302

7491

6420X

ICD-9 Finland

Hypertension complicating pregnancy, childbirth and the puerperium, Benign essential hypertension complicating pregnancy, childbirth and the puerperium

8.2

69.8

160

196

E11.9

ICD-10 Finland

Type 2 diabetes mellitus, without complications

1.8

69.0

1441

8603

C07AB07

ATC

bisoprolol; oral

1.4

67.0

3607

27159

W92

ICPC

Compl labour/ delivery livebirth

2.6

66.9

527

2090

MAC40

NOMESCO Finland

Pharmacological induction or advancement of labor

2.8

66.7

460

1688

SPAT1357

SPAT

Monitoring of problem during pregnancy

2.2

64.3

675

3101

T90

ICPC

Diabetes non-insulin dependent

1.7

64.0

1584

9929

SPAT1249

SPAT

Treatment-related counselling outside office

1.4

62.0

5081

41136

O99.80

ICD-10 Finland

The fear of childbirth

1.8

61.1

1094

6204

B01AB05

ATC

enoxaparin; parenteral

1.5

60.7

2978

21925

O99.2

ICD-10 Finland

Endocrine, nutritional and metabolic diseases complicating pregnancy, childbirth and the puerperium

2.7

60.7

431

1609

C09BA02

ATC

enalapril and diuretics; systemic

2.5

60.7

518

2148

O16

ICD-10 Finland

Unspecified maternal hypertension

6.4

60.0

162

253

MA2JE

NOMESCO Finland

Ultrasound screening of fetal nuchal translucency

1.6

58.8

1842

12268

O35.8

ICD-10 Finland

Maternal care for other (suspected) fetal abnormality and damage

2.6

58.2

452

1776

O99.89

ICD-10 Finland

Other specified diseases and conditions complicating pregnancy, childbirth and the puerperium

2.5

56.9

478

1965

C09CA01

ATC

losartan; oral

1.6

55.4

1750

11662

A10AB01

ATC

insulin (human); parenteral (insulins and analog. for injection, fast-acting)

2.5

55.4

464

1902

A10AE05

ATC

insulin detemir; parenteral

2.3

54.5

537

2392

O99.3

ICD-10 Finland

Mental disorders and diseases of the nervous system complicating pregnancy, childbirth and the puerperium

2.5

51.8

438

1804

WX602

NOMESCO Finland

Repeated or continuing anesthesia shots throug a catheter

1.6

50.6

1488

9725

66180

ICD-8 Finland

Occipital presentation

3.0

50.2

309

1056

E10.3

ICD-10 Finland

Type 1 diabetes mellitus, With ophthalmic complications

2.5

49.9

408

1652

C03CA01

ATC

furosemide; systemic

1.6

49.4

1444

9418

WX306

NOMESCO Finland

Lumbar epidural anesthesy

1.6

48.9

1311

8359

E10.9

ICD-10 Finland

Type 1 diabetes mellitus, Without complications

2.2

48.4

534

2507

SPAT1250

SPAT

Comprehensive monitoring of chronic illness

1.5

47.6

1901

13326

E10.7

ICD-10 Finland

Type 1 diabetes mellitus, With multiple complications

3.0

46.6

282

953

A10AB04

ATC

insulin lispro; parenteral (insulins and analog. for injection, fast-acting)

2.4

46.4

430

1857

O28.8

ICD-10 Finland

Other abnormal findings on antenatal screening of mother

3.1

46.3

269

884

ZXE00

NOMESCO Finland

One hour or less

1.3

46.2

4820

39940

LX1AE

NOMESCO Finland

Gynecological ultrasound examination as part of clinical examination

1.5

45.5

1974

14068

40199

ICD-8 Finland

Essential benign hypertension

5.6

45.3

136

245

C02EA02

ATC

3.7

44.8

203

553

25000

ICD-8 Finland

Diabetes mellitus, Sine complicatione

3.1

44.6

258

846

O80.0

ICD-10 Finland

Spontaneous vertex delivery

1.3

44.2

5143

43195

C03EA01

ATC

hydrochlorothiazide and potassium-sparing agents; oral

1.6

44.0

1218

7822

O35.1

ICD-10 Finland

Maternal care for (suspected) chromosomal abnormality in fetus

2.2

43.3

442

2000

J01DB01

ATC

cefalexin; oral

1.3

43.1

10400

96399

C08CA13

ATC

lercanidipine; oral

1.8

42.9

835

4850

WX307

NOMESCO Finland

Obstetric epidural analgesia

1.5

42.6

1652

11485

O30.00

ICD-10 Finland

Twin pregnancy with separate amniotic and chorionic sacs

5.1

42.6

139

276

A10AA02

ATC

2.4

42.4

363

1508

T89

ICPC

Diabetes insulin dependent

2.2

41.7

442

2039

285

Kela drug reimbursment

Dulaglutide, exenatide, liraglutide, lixisenatide and semaglutide (adults)

2.2

41.4

442

2046

SPAT1301

SPAT

No procedures

1.3

41.3

3277

25956

C08CA02

ATC

felodipine; oral

2.1

41.1

500

2448

J01DA01

ATC

[U] cefalexin; systemic

1.3

40.9

7802

69657

A10AA01

ATC

2.4

40.9

351

1461

C09DA01

ATC

losartan and diuretics; oral

1.8

40.3

733

4162

6440B

ICD-9 Finland

Early or threatened labour, Threatened premature labour[PARTUS PRAEMATURUS]

2.8

40.2

263

936

O61.0

ICD-10 Finland

Failed medical induction of labour

2.9

39.9

254

889

6563B

ICD-9 Finland

Other foetal and placental problems affecting management of mother, Foetal distress[ASPHYXIA FOETALIS, SYNNYTYKSEN AIKANA]

2.5

39.3

317

1273

346

Kela drug reimbursment

Dulaglutide, exenatide, liraglutide, lixisenatide and semaglutide (adults)

2.2

39.0

407

1860

ZXD00

NOMESCO Finland

Emergency procedure

2.1

38.2

434

2063

C09AA05

ATC

ramipril; oral

1.5

37.8

1277

8592

MAX99

NOMESCO Finland

Assistance to normal delivery

1.4

37.6

1882

13750

Z30.2

ICD-10 Finland

Sterilization

1.5

37.0

1652

11799

O12.2

ICD-10 Finland

Gestational oedema with proteinuria

12.5

36.5

SPAT1399

SPAT

Acceptance of acknowledgement of paternity of child born outside of marriage before the birth of the child at the maternity clinic. Paternity Act, Section 16.

1.7

36.3

805

4858

O02.1

ICD-10 Finland

Missed abortion

1.6

36.2

1034

6681

W29

ICPC

Pregnancy symptom/complaint other

1.9

36.2

532

2806

SPAT1310

SPAT

Counselling related to known health issue

1.3

35.9

3534

28766

C09CA06

ATC

candesartan; oral

1.4

35.7

2064

15464

C02AC05

ATC

moxonidine; oral

2.6

35.4

261

998

E66.8

ICD-10 Finland

Other obesity

1.7

35.4

769

4613

63700

ICD-8 Finland

Pre-eclampsia, eclampsia and toxaemia, unspecified, Albuminuria (proteinuria)

4.3

35.3

133

308

N02BE01

ATC

paracetamol; systemic, rectal

1.3

34.9

10592

99234

O26.82

ICD-10 Finland

Exhaustion and fatigue pregnancy-related

2.1

34.8

409

1974

WX290

NOMESCO Finland

Other blockade of nerve

1.3

34.8

6092

53320

O10.9

ICD-10 Finland

Unspecified pre-existing hypertension complicating pregnancy, childbirth and the puerperium

7.7

34.3

106

H04AA01

ATC

glucagon; nasal, parenteral

2.3

34.3

324

1414

C03AA03

ATC

hydrochlorothiazide; oral

1.8

34.2

612

3457

SPAT1189

SPAT

Other ultrasound examination during pregnancy

1.8

34.0

648

3736

O20.9

ICD-10 Finland

Haemorrhage in early pregnancy, unspecified

1.8

33.8

569

3150

W85

ICPC

Gestational diabetes

1.7

33.8

775

4723

Z39.1

ICD-10 Finland

Care and examination of lactating mother

2.0

33.4

422

2100

K02.1

ICD-10 Finland

Caries of dentine

1.2

33.4

7408

66510

A10BK03

ATC

empagliflozin; oral

1.9

33.3

503

2678

FM1EE

NOMESCO Finland

Extensive structural and functional ultrasound examination of heart

1.5

33.1

1380

9707

A10BB12

ATC

glimepiride; oral

2.4

32.8

280

1164

MA5AE

NOMESCO Finland

Morphology ultrasound screening, weeks 18+0 to 21+6 of gestation

1.6

32.7

855

5398

O12.0

ICD-10 Finland

Gestational oedema

3.9

32.7

137

351

2500B

ICD-9 Finland

Diabetes mellitus without mention of complication[DIABETES MELLITUS SINE COMPLICATIONE ,TYYPPI I]

2.4

32.2

285

1207

W90

ICPC

Uncompl labour/delivery livebirth

1.6

32.0

879

5619

O20.0

ICD-10 Finland

Threatened abortion

1.9

31.7

504

2734

O82.11

ICD-10 Finland

Childbirth with an emergency caesarean section in an emergency

2.6

31.6

238

924

6480A

ICD-9 Finland

Other current conditions in the mother classifiable elsewhere but complicating pregnancy, childbirth and the puerperium, Diabetes mellitus

3.7

31.1

139

377

C09DA06

ATC

candesartan and diuretics; oral

1.8

31.0

522

2890

C02CB01

ATC

11.9

30.9

O36.3

ICD-10 Finland

Maternal care for signs of fetal hypoxia

3.5

30.9

150

435

E11.7

ICD-10 Finland

Type 2 diabetes mellitus, with multiple complications

2.9

30.9

198

699

O84.2

ICD-10 Finland

Multiple delivery, all by caesarean section

3.9

30.8

129

331

O26.88

ICD-10 Finland

Other specified pregnancy-related conditions

2.3

30.8

301

1340

E66.00

ICD-10 Finland

Metabolic syndrome

1.9

30.7

474

2545

W81

ICPC

Toxaemia of pregnancy

15.0

30.7

Z3232

NOMESCO Finland

Midwife

1.4

30.6

1748

13034

O21.9

ICD-10 Finland

Vomiting of pregnancy, unspecified

2.3

30.6

288

1257

GD1AA

NOMESCO Finland

Thorax X-ray examination

1.3

30.1

3453

28554

R10.4

ICD-10 Finland

Other and unspecified abdominal pain

1.3

30.1

4510

38531

K85

ICPC

Elevated blood pressure

1.5

29.7

1009

6785

O72.2

ICD-10 Finland

Delayed and secondary postpartum haemorrhage

2.1

29.4

324

1522

A10BH01

ATC

sitagliptin; oral

1.8

29.3

533

3025

C10AA01

ATC

simvastatin; oral

1.3

29.2

2188

17038

A12BA01

ATC

potassium chloride; oral

2.7

29.2

200

736

Z35.0

ICD-10 Finland

Supervision of pregnancy with history of infertility

1.8

29.2

552

3173

E10.2

ICD-10 Finland

Type 1 diabetes mellitus, With renal complications

3.9

29.1

123

318

O99.4

ICD-10 Finland

Diseases of the circulatory system complicating pregnancy, childbirth and the puerperium

3.5

29.1

138

393

LC2BE

NOMESCO Finland

Transvaginal ultrasound examination of uterus, parametria and lower abdomen

1.2

29.1

4962

42977

G56.0

ICD-10 Finland

Carpal tunnel syndrome

1.4

28.9

1484

10850

FM1QE

NOMESCO Finland

Extensive ultrasound of fetal heart

3.0

28.5

165

545

Z35.4

ICD-10 Finland

Supervision of pregnancy with grand multiparity

3.0

28.1

163

539

MA3AE

NOMESCO Finland

Combined first trimester screening

1.6

27.8

815

5287

O36.8

ICD-10 Finland

Maternal care for other specified fetal problems

2.1

27.8

315

1496

J01CA08

ATC

pivmecillinam; oral

1.2

27.8

6318

56339

SPAT1306

SPAT

Counselling and guidance related to nutrition and weight management

1.4

27.7

1346

9738

O15.0

ICD-10 Finland

Eclampsia in pregnancy

281.2

27.7

WX110

NOMESCO Finland

Local anesthesy

1.2

27.3

8743

80748

O24.1

ICD-10 Finland

Diabetes mellitus in pregnancy: Pre-existing diabetes mellitus, non-insulin-dependent

3.4

27.2

136

405

SAA01

NOMESCO Finland

Simple examination of mouth

1.2

27.1

9285

86341

E11

ICD-10 Finland

Type 2 diabetes mellitus

1.5

27.1

897

5991

E66.9

ICD-10 Finland

Obesity, unspecified

1.8

27.1

449

2474

A10BJ06

ATC

semaglutide; parenteral

2.2

27.0

287

1329

I25.1

ICD-10 Finland

Atherosclerotic heart disease

1.7

26.7

600

3633

K86

ICPC

Hypertension uncomplicated

1.6

26.5

675

4229

WX321

NOMESCO Finland

Acute spinal anesthesia for delivery

1.6

26.4

762

4927

H36.09*E10.3

ICD-10 Finland

Insulin-dependent diabetes mellitus - Diabetic retinopathy

3.3

26.3

136

415

SGA01

NOMESCO Finland

Tooth opening as first aid

1.3

26.2

1966

15284

H3603, E103

ICD-10 Finland

3.2

26.2

141

444

EB1AA

NOMESCO Finland

Tooth X-ray examination

1.2

25.9

6807

61418

J01.0

ICD-10 Finland

Acute maxillary sinusitis

1.3

25.9

3126

25924

C10AA05

ATC

atorvastatin; oral

1.3

25.8

2117

16674

WZB00

NOMESCO Finland

Telephone receipt or other advice

1.2

25.8

3655

30885

A10AE06

ATC

insulin degludec; parenteral

2.1

25.6

292

1393

SFA10

NOMESCO Finland

Fillning on one surface of tooth

1.2

25.5

6614

59549

LGA10

NOMESCO Finland

Sterilisation by destruction or division of Fallopian tubes

2.7

25.5

181

680

C07AG02

ATC

carvedilol; oral

2.1

25.4

295

1420

R51.80

ICD-10 Finland

Headache

1.3

25.1

1891

14704

SPAT1153

SPAT

Removal of sutures

1.3

24.8

2818

23168

WX892

NOMESCO Finland

Monitored bed care

1.7

24.7

511

3019

FM1NE

NOMESCO Finland

Ultrasound examination of fetal heart

3.5

24.7

118

340

MBA03

NOMESCO Finland

Curettage of uterus after delivery or abortion

1.7

24.6

536

3214

6462A

ICD-9 Finland

Other complications of pregnancy, not elsewhere classified, Unspecified renal disease in pregnancy, without mention of hypertension

6.2

24.5

106

4019X

ICD-9 Finland

Essential hypertension, Unspecified

3.8

24.2

103

270

R10.3

ICD-10 Finland

Pain localized to other parts of lower abdomen

1.2

24.1

3312

27842

6427A

ICD-9 Finland

Hypertension complicating pregnancy, childbirth and the puerperium, Pre-eclampsia or eclampsia superimposed on pre-existing hypertension[PRAE-ECL SEU ECL CUM HYPERT ART,ENNEN SYNNYTYSTÄ]

+∞

23.9

SPAT1223

SPAT

Implementation of physical therapy rehabilitation plan

1.3

23.9

2707

22232

E11.8

ICD-10 Finland

Type 2 diabetes mellitus, with unspecified complications

1.8

23.8

403

2238

H3600, E103

ICD-10 Finland

2.8

23.7

154

550

SFA20

NOMESCO Finland

Filling on two surfaces of tooth

1.2

23.6

7374

67381

160

Kela drug reimbursment

exenatide

2.7

23.4

166

626

O68.8

ICD-10 Finland

Labour and delivery complicated by other evidence of fetal stress

2.4

23.1

194

801

V230A

ICD-9 Finland

Supervision of high-risk pregnancy, Pregnancy with history of infertility

2.6

23.0

171

662

206

Kela drug reimbursment

Chronic coronary artery disease and dyslipidaemia associated with chronic coronary artery disease

1.8

22.9

434

2495

O99.6

ICD-10 Finland

Diseases of the digestive system complicating pregnancy, childbirth and the puerperium

2.5

22.7

180

723

FN1AC

NOMESCO Finland

Angiography of heart and/or coronary arteries

1.5

22.6

804

5452

O46.9

ICD-10 Finland

Antepartum haemorrhage, unspecified

1.9

22.6

335

1777

SFC01

NOMESCO Finland

Adjuvant procedure of filling therapy

1.3

22.6

2880

23965

O35.9

ICD-10 Finland

Maternal care for (suspected) fetal abnormality and damage, unspecified

2.4

22.6

201

858

O36.4

ICD-10 Finland

Maternal care for intrauterine death

3.2

22.5

122

387

65700

ICD-8 Finland

Occipital presentation

2.9

22.5

137

471

WYA05

NOMESCO Finland

Emergency visit or other similar visit involving procedures

1.2

22.4

6052

54415

O10.1

ICD-10 Finland

Pre-existing hypertensive heart disease complicating pregnancy, childbirth and the puerperium

11.7

22.3

6563A

ICD-9 Finland

Other foetal and placental problems affecting management of mother, Foetal distress[ASPHYXIA FOETALIS, RASKAUDEN AIKANA]

6.0

22.0

102

O26.6

ICD-10 Finland

Liver disorders in pregnancy, childbirth and the puerperium

2.0

22.0

288

1458

SPAT1312

SPAT

General health counselling

1.2

21.8

3646

31250

N02AA59

ATC

codeine, combinations excl. psycholeptics; systemic

1.2

21.7

5053

44753

A10BJ02

ATC

liraglutide; parenteral

2.3

21.5

196

845

O99.1

ICD-10 Finland

Other diseases of the blood and blood-forming organs and certain disorders involving the immune mechanism complicating pregnancy, childbirth and the puerperium

2.6

21.3

152

576

C01DA08

ATC

isosorbide dinitrate; oral, oral aerosol, sublingual, transdermal

1.5

21.2

844

5863

O84.0

ICD-10 Finland

Multiple delivery, all spontaneous

2.8

21.0

138

497

EB1HA

NOMESCO Finland

Panorama tomography of teeth and jaws or similar X-ray examination

1.2

21.0

4547

39951

G47.3

ICD-10 Finland

Sleep apnoea

1.3

20.9

1529

11813

A10AD01

ATC

insulin (human); parenteral (insulins and analog. for injection, intermediate- or long-acting comb. with fast-acting)

2.5

20.9

161

638

O47.9

ICD-10 Finland

False labour, unspecified

1.9

20.9

310

1646

O43.8

ICD-10 Finland

Other placental disorders

8.5

20.7

H3601, E103

ICD-10 Finland

3.0

20.7

120

400

Z36.4

ICD-10 Finland

Antenatal screening for fetal growth retardation using ultrasound and other physical methods

2.0

20.6

281

1446

O99.5

ICD-10 Finland

Diseases of the respiratory system complicating pregnancy, childbirth and the puerperium

2.5

20.6

160

638

R07.4

ICD-10 Finland

Chest pain, unspecified

1.3

20.6

2027

16322

E11.3

ICD-10 Finland

Type 2 diabetes mellitus, with ophthalmic complications

2.6

20.5

147

558

A10BK01

ATC

dapagliflozin; oral

1.9

20.4

292

1527

O03.9

ICD-10 Finland

Spontaneous abortion, Complete or unspecified, without complication

1.5

20.4

743

5069

M54.5

ICD-10 Finland

Low back pain

1.2

20.3

3786

32763

SPAT1253

SPAT

Initiation, adjustment, discontinuation or repetition of medication

1.2

20.2

3267

27853

TMW99

NOMESCO Finland

Other minor surgical procedure in obstetrics

2.4

20.1

170

708

Z32.0

ICD-10 Finland

Pregnancy, not (yet) confirmed

1.7

20.1

456

2772

SPAT1097

SPAT

Recording of ECG

1.4

20.0

1008

7324

Z39.0

ICD-10 Finland

Care and examination immediately after delivery

2.1

19.9

215

1008

Z71.3

ICD-10 Finland

Dietary counselling and surveillance

1.6

19.9

513

3228

SPAT1315

SPAT

Periodic health check-up of children and adolescents

1.6

19.8

561

3612

P01AB01

ATC

metronidazole; oral, rectal

1.2

19.8

5058

45063

SPAT1008

SPAT

Photography of fundus of the eye or interpretation of photograph

2.1

19.8

239

1172

123

Kela drug reimbursment

Chronic disorders of vitamin D metabolism

2.9

19.7

121

420

A02BC01

ATC

omeprazole; systemic

1.2

19.6

2591

21606

O24.9

ICD-10 Finland

Diabetes mellitus in pregnancy, unspecified

1.8

19.5

317

1738

E10.1

ICD-10 Finland

Type 1 diabetes mellitus, With ketoacidosis

2.6

19.2

143

555

Z34.0

ICD-10 Finland

Supervision of normal first pregnancy

1.3

19.1

2346

19386

O28.3

ICD-10 Finland

Abnormal ultrasonic finding on antenatal screening of mother

2.5

19.0

146

578

O03.4

ICD-10 Finland

Spontaneous abortion, Incomplete, without complication

1.7

19.0

385

2267

SPAT1254

SPAT

Administration of medicine

1.4

18.9

1090

8103

PH2AE

NOMESCO Finland

Ultrasound examination of lower leg veins

1.4

18.9

910

6560

SPAT1283

SPAT

Restricted health certificate

1.2

18.6

2862

24242

Z35.7

ICD-10 Finland

Supervision of high-risk pregnancy due to social problems

3.7

18.6

224

XCK10

NOMESCO Finland

Photography of fundus of eye

1.5

18.4

644

4356

O35.6

ICD-10 Finland

Maternal care for (suspected) damage to fetus by radiation

43.9

18.2

310

Kela drug reimbursment

Orlistat, sibutramine and other major and expensive medicines used to treat obesity

2.8

18.1

120

435

SFA30

NOMESCO Finland

Filling on tree or more surfaces of tooth

1.2

18.1

4376

38697

C10AA07

ATC

rosuvastatin; oral

1.3

18.1

1488

11683

E10.8

ICD-10 Finland

Type 1 diabetes mellitus, With unspecified complications

2.6

18.1

133

516

K04.0

ICD-10 Finland

Pulpitis

1.3

18.0

1218

9291

C07FB02

ATC

metoprolol and felodipine; systemic

2.5

17.9

139

556

63702

ICD-8 Finland

Pre-eclampsia, eclampsia and toxaemia, unspecified, Oedema

3.2

17.9

300

C09CA03

ATC

valsartan; oral

1.6

17.8

487

3111

SPAT1256

SPAT

Intramuscular and subcutaneous injection

1.2

17.8

3903

34202

SPAT1260

SPAT

Consultation of another employee

1.3

17.7

1676

13400

J01FF01

ATC

clindamycin; systemic

1.2

17.7

2704

22866

Z37.2

ICD-10 Finland

Twins, both liveborn

3.6

17.5

215

O36.6

ICD-10 Finland

Maternal care for excessive fetal growth

1.5

17.5

607

4097

SPAT1246

SPAT

Screening of depression or other psychiatric problem

1.5

17.4

700

4872

O45.9

ICD-10 Finland

Premature separation of placenta, unspecified

3.6

17.4

216

SPAT1230

SPAT

Aid fitting and borrowing and monitoring of use

1.3

17.4

1306

10115

N08.39*E10.2

ICD-10 Finland

Insulin-dependent diabetes mellitus - Diabetic nephropathy

3.6

17.3

212

H36.03

ICD-10 Finland

Proliferative diabetic retinopathy

3.2

17.3

280

O99.0

ICD-10 Finland

Anaemia complicating pregnancy, childbirth and the puerperium

2.1

17.3

186

872

M04AA01

ATC

allopurinol; systemic

1.7

17.2

397

2426

LGA20

NOMESCO Finland

Sterilisation by constriction of Fallopian tubes

2.2

17.2

180

833

177

Kela drug reimbursment

Insulin glargine 300 U / ml

2.2

17.1

169

761

C01DA14

ATC

isosorbide mononitrate; oral

1.7

17.1

360

2143

C07AB08

ATC

celiprolol; oral

2.7

17.1

118

440

J01CA04

ATC

amoxicillin; systemic

1.2

17.1

10501

100303

C07AB03

ATC

atenolol; systemic

1.8

17.1

286

1587

JN3AE

NOMESCO Finland

Abdominal ultrasound examination

1.3

16.9

1105

8384

N02AX02

ATC

tramadol; systemic, rectal

1.2

16.8

3797

33316

138

Kela drug reimbursment

Severe anaemia associated with chronic renal failure

2.8

16.8

112

408

6426A

ICD-9 Finland

Hypertension complicating pregnancy, childbirth and the puerperium, Eclampsia[ECLAMPSIA , ENNEN SYNNYTYSTÄ]

+∞

16.6

T81.4

ICD-10 Finland

Infection following a procedure, not elsewhere classified

1.4

16.6

997

7465

N02AE01

ATC

buprenorphine; parenteral, sublingual, transdermal

1.4

16.5

723

5117

O04.9

ICD-10 Finland

Medical abortion, complete or unspecified, without complication

1.3

16.5

1526

12164

MWE00

NOMESCO Finland

Reoperation for deep haemorrhage in obstetric surgery

5.0

16.4

104

N71.0

ICD-10 Finland

Acute inflammatory disease of uterus

1.6

16.3

473

3066

E78.01

ICD-10 Finland

Pure hypercholesterolaemia

1.3

16.3

1040

7859

8221

FHL

Sterilization of the laparotomy pathway

1.7

16.3

335

1982

E10

ICD-10 Finland

Type 1 diabetes mellitus

2.0

16.3

197

970

O02.0

ICD-10 Finland

Blighted ovum and nonhydatidiform mole

1.5

16.3

530

3530

SAA02

NOMESCO Finland

Basic examination of mouth

1.2

16.2

8469

79501

WX234

NOMESCO Finland

Paracervical blockade

1.5

16.2

494

3239

C09AA03

ATC

lisinopril; oral

1.9

16.2

235

1242

6488A

ICD-9 Finland

Other current conditions in the mother classifiable elsewhere but complicating pregnancy, childbirth and the puerperium, Abnormal glucose tolerance

2.0

16.1

216

1107

Y6099

ICD-8 Finland

Prenatal care and observation

1.6

16.1

453

2916

SPAT1240

SPAT

Therapeutic discussion

1.3

16.0

1450

11524

W05

ICPC

Pregnancy vomiting/nausea

2.2

15.9

166

768

A10BX07

ATC

[U] liraglutide; parenteral

2.8

15.9

103

371

Z35

ICD-10 Finland

Supervision of high-risk pregnancy

2.1

15.9

183

884

O30.01

ICD-10 Finland

Twin pregnancy with a shared chorionic sac and a separate amniotic sac

5.3

15.9

Z36.8

ICD-10 Finland

Other antenatal screening

1.7

15.8

358

2177

SPAT1200

SPAT

Guidance for breast-feeding and breast care

1.5

15.8

476

3112

MBA00

NOMESCO Finland

Vacuum aspiration from uterus after delivery or abortion

1.6

15.7

372

2288

6542B

ICD-9 Finland

Abnormality of organs and soft tissues of pelvis, Previous Caesarean delivery[CICATRIX UTERI POSTOPERATIVA, SYNNYTYKSEN AIKANA]

2.3

15.7

143

621

Z95.1

ICD-10 Finland

Presence of aortocoronary bypass graft

3.4

15.7

225

Z01.0

ICD-10 Finland

Examination of eyes and vision

1.3

15.7

1400

11102

O46.0

ICD-10 Finland

Antepartum haemorrhage with coagulation defect

11.1

15.7

O15.1

ICD-10 Finland

Eclampsia in labour

+∞

15.6

ACC59

NOMESCO Finland

Decompression and freeing of adhesions of peripheral nerve: other or unspecified

1.6

15.6

380

2356

WYA40

NOMESCO Finland

Assessment of oral health and treatment needs for family expecting first child

1.7

15.5

298

1727

TPH04

NOMESCO Finland

Cathetrisation of vein

1.3

15.5

1680

13647

O14

ICD-10 Finland

Pre-eclampsia

17.1

15.5

I15.1

ICD-10 Finland

Hypertension secondary to other renal disorders

3.2

15.5

249

6542A

ICD-9 Finland

Abnormality of organs and soft tissues of pelvis, Previous Caesarean delivery[CICATRIX UTERI POSTOPERATIVA, RASKAUDEN AIKANA]

3.2

15.4

244

AA1AD

NOMESCO Finland

CT of head and brain

1.3

15.4

1535

12340

M75.1

ICD-10 Finland

Rotator cuff syndrome

1.2

15.3

1987

16480

SGC10

NOMESCO Finland

Covering pulpa of tooth

1.3

15.3

1125

8685

FNA01

NOMESCO Finland

Anastomosis to coronary artery from internal mammary artery, one distal anastamosis

3.1

15.2

269

H36.01

ICD-10 Finland

Diabetic maculopathy

3.0

15.2

302

N02AJ06

ATC

codeine and paracetamol; systemic

1.2

15.1

3919

34731

SPAT1192

SPAT

Gynaecological examination

1.2

15.1

1785

14654

JDF11

NOMESCO Finland

Laparoscopic gastric bypass

1.9

15.0

234

1269

K80.2

ICD-10 Finland

Calculus of gallbladder without cholecystitis

1.3

15.0

1163

9041

C09DA03

ATC

valsartan and diuretics; oral

1.8

15.0

268

1522

H36.00

ICD-10 Finland

Diabetic background retinopathy

2.5

14.9

117

473

A08AB01

ATC

orlistat; oral

3.2

14.9

235

K04.5

ICD-10 Finland

Chronic apical periodontitis

1.2

14.8

2276

19212

CKC12

NOMESCO Finland

Photocoagulation of retina

1.7

14.8

300

1769

C03BA11

ATC

indapamide; oral

2.1

14.8

160

752

J01AA02

ATC

doxycycline; systemic

1.2

14.8

9213

87320

O26.7

ICD-10 Finland

Subluxation of symphysis (pubis) in pregnancy, childbirth and the puerperium

2.0

14.8

188

947

6510A

ICD-9 Finland

Multiple gestation, Twin pregnancy[GEMINI, RASKAUDEN AIKANA]

3.3

14.6

227

T81.0

ICD-10 Finland

Haemorrhage and haematoma complicating a procedure, not elsewhere classified

1.5

14.6

559

3857

Z37.0

ICD-10 Finland

Single live birth

1.2

14.5

1738

14279

I21.41

ICD-10 Finland

Acute subendocardial infarction stenosed coronary artery

2.3

14.5

127

543

D50.9

ICD-10 Finland

Iron deficiency anaemia, unspecified

1.4

14.4

586

4093

C07BB07

ATC

bisoprolol and thiazides; systemic

1.8

14.4

247

1386

T82

ICPC

Obesity

1.5

14.3

450

2974

EBA00

NOMESCO Finland

Extraction of tooth

1.2

14.3

3382

29707

W27

ICPC

Fear of complications of pregnancy

2.0

14.2

179

897

SPAT1028

SPAT

Ultrasound examination of paranasal sinuses

1.4

14.2

712

5169

M79.6

ICD-10 Finland

Pain in limb

1.2

14.1

3768

33437

B01AC04

ATC

clopidogrel; oral

1.5

14.1

497

3370

O61.1

ICD-10 Finland

Failed instrumental induction of labour

3.5

14.0

187

N18.9

ICD-10 Finland

Chronic kidney disease, unspecified

2.0

14.0

173

862

C10AX09

ATC

ezetimibe; oral

1.5

13.9

524

3602

BEF00

NOMESCO Finland

Continuous subcutaneous glucose monitoring

2.5

13.8

104

412

UJD10

NOMESCO Finland

Esophagoscopy, gastroscopy and duodenoscopy

1.2

13.8

2396

20455

TPH07

NOMESCO Finland

Cathetrisation of artery

1.4

13.8

594

4194

E11.2

ICD-10 Finland

Type 2 diabetes mellitus, with renal complications

2.7

13.7

351

C08CA10

ATC

nilvadipine; oral

2.5

13.6

103

409

SPAT1190

SPAT

Insertion or removal of intrauterine contraceptive device

1.3

13.5

1066

8311

C08DB01

ATC

diltiazem; oral

1.9

13.5

187

976

25009

ICD-8 Finland

Diabetes mellitus, Unspecified

3.6

13.4

168

JKA21

NOMESCO Finland

Laparoscopic cholecystectomy

1.3

13.4

1124

8831

A10BD07

ATC

metformin and sitagliptin; systemic

1.8

13.4

210

1146

E11.00

ICD-10 Finland

Non-insulin dependent diabetes diabetic hypoglycaemic coma

2.4

13.3

110

459

SPAT1307

SPAT

Psychosocial counselling and guidance

1.3

13.3

826

6217

SGC00

NOMESCO Finland

Local medication of root channels of tooth

1.3

13.3

1215

9661

QBJ30

NOMESCO Finland

Correction of abdominal apron

2.2

13.2

136

627

N39.0

ICD-10 Finland

Urinary tract infection, site not specified

1.3

13.1

1232

9826

A10BG03

ATC

pioglitazone; oral

2.3

13.1

121

533

H43.1

ICD-10 Finland

Vitreous haemorrhage

2.1

13.1

150

724

O72.1

ICD-10 Finland

LabWAS

↥

(ID) Name

N Cases

N Controls

-log₁₀(p)

cases

controls

unit

cases

controls

-log₁₀(p)

N cases

N controls

(3020682) Albumin/Creatinine [Ratio] in Urine

4187

24065

2.02

293.42

5.0

3.8

mg/mmol

23.3

7.3

37.56

2883

14280

(3012516) Albumin [Mass/volume] in Urine

4026

23024

2.02

284.70

4.0

3.2

mg/l

393.4

500.0

0.82

2752

13399

(3009508) Creatinine [Moles/volume] in Urine

4469

27803

1.86

238.07

4.1

3.0

mmol/l

10.3

7.3

0.47

3901

23867

(3022250) Lactate dehydrogenase [Enzymatic activity/volume] in Serum or Plasma by Lactate to pyruvate reaction

1760

8836

2.12

168.34

3.9

3.8

u/l

240.3

231.1

0.95

1678

8358

(3020321) Streptococcus agalactiae [Presence] in Vaginal fluid by Organism specific culture

1699

8562

2.11

160.46

1.7

1.5

—

(1002102) Choriogonadotropin.intact+Beta subunit [Mass/volume] in Serum or Plasma

1285

6236

2.16

132.67

1.5

1.4

—

(3012336) Haptoglobin [Mass/volume] in Serum or Plasma

786

3113

2.60

128.97

3.0

1.7

g/l

1.2

1.4

13.88

703

2680

(21492888) Glucose tolerance 2 hours gestational panel - Serum or Plasma

1477

7688

2.02

126.14

1.9

1.8

—

(3021584) Pregnancy associated plasma protein A [Units/volume] in Serum or Plasma

2762

17657

1.69

120.58

1.6

1.5

—

(3026493) Urate [Moles/volume] in Serum or Plasma

3782

26448

1.57

113.72

2.8

2.0

umol/l

2192.5

2629.4

0.44

3398

23414

(3019284) Hepatitis B virus surface Ag [Presence] in Serum

4520

33947

1.47

93.18

1.9

1.7

—

(3019832) Treponema pallidum Ab [Presence] in Serum

3705

27092

1.49

86.06

1.8

1.7

—

(3013826) Glucose [Moles/volume] in Serum or Plasma

7486

63235

1.36

72.36

4.6

3.8

mmol/l

6.6

6.3

15.95

6707

57130

(3023103) Potassium [Moles/volume] in Serum or Plasma

13159

123048

1.59

67.07

12.5

10.4

mmol/l

3.9

10.24

12859

119561

(3019550) Sodium [Moles/volume] in Serum or Plasma

13126

122699

1.58

66.64

12.3

10.3

mmol/l

139.4

139.6

18.95

12849

119509

(3037467) Urinalysis macro (dipstick) panel - Urine

9846

87552

1.36

64.37

4.6

4.0

—

(3029937) Albumin [Presence] in Urine by Test strip

4253

33300

1.38

63.89

4.2

3.6

estimate

0.0

0.03

1731

12402

(3016407) Fibrinogen [Mass/volume] in Platelet poor plasma by Coagulation assay

710

3605

2.01

63.76

2.6

2.4

g/l

3.9

3.5

9.79

657

3409

(3032080) INR in Blood by Coagulation assay

4419

34914

1.37

62.47

5.6

5.2

inr

1.1

0.66

1605

11339

(3034274) Bile acid [Moles/volume] in Serum --fasting

739

3852

1.96

61.54

2.4

2.1

umol/l

5.4

5.2

0.13

542

2780

(40763086) Leukocyte esterase [Presence] in Urine by Automated test strip

5922

49109

1.34

60.47

3.9

3.3

—

(3031040) Bacteria [#/volume] in Urine by Automated count

9505

84443

1.34

60.03

4.6

3.9

e6/l

706.9

1876.3

2.85

100

910

(3035350) Ketones [Presence] in Urine by Test strip

7299

62882

1.31

54.84

3.9

3.2

estimate

0.0

1.56

1720

12135

(3009261) Glucose [Presence] in Urine by Test strip

7378

63739

1.31

53.93

3.9

3.3

estimate

0.0

0.66

1716

12370

(3026008) Bacteria identified in Urine by Culture

4436

35714

1.34

53.57

2.8

2.5

—

(3001079) Blood group antibody screen [Presence] in Serum or Plasma

7086

61012

1.30

52.52

4.3

3.8

—

(3021601) Nitrite [Presence] in Urine by Test strip

7305

63233

1.30

51.67

5.1

4.4

estimate

0.0

0.03

1771

12470

(3050129) First trimester maternal screen panel - Serum or Plasma

1731

11905

1.51

51.22

1.5

1.4

—

(3041096) Erythrocytes [Presence] in Urine by Automated

4454

36300

1.32

48.21

3.3

2.8

—

(40761536) Microorganisms panel - Urine sediment

1611

11281

1.48

43.16

4.0

3.3

—

(3019800) Troponin T.cardiac [Mass/volume] in Serum or Plasma

4245

34776

1.30

43.14

2.8

2.6

ng/l

29.9

49.0

0.46

2088

15765

(3037121) Protein [Mass/volume] in Urine

578

3136

1.87

42.52

3.2

2.8

g/l

0.5

0.2

6.49

281

1165

(3050449) Albumin [Mass/time] in Urine collected for unspecified duration

351

1595

2.22

42.12

2.8

2.4

ug/min

138.1

58.7

1.78

229

986

(43054914) Glucose tolerance 2 hours panel - Serum or Plasma

2581

19763

1.37

41.53

2.0

—

(46235355) HIV 1 and 2 tests - Meaningful Use set

4776

39954

1.28

40.75

2.0

—

(3051714) Fibrin D-dimer FEU [Mass/volume] in Platelet poor plasma

3564

28830

1.31

39.00

2.1

1.7

mg/l

1.3

0.9

6.41

2711

21432

(3020876) Protein [Mass/time] in 24 hour Urine

173

582

2.99

38.73

2.8

1.8

g/24h

1.7

0.9

0.92

(3018171) Choriogonadotropin [Units/volume] in Serum or Plasma

1755

12814

1.42

37.22

2.6

2.2

u/l

8158.0

5917.9

2.05

823

5242

(3024561) Albumin [Mass/volume] in Serum or Plasma

5197

44522

1.25

34.83

5.0

4.2

g/l

35.8

36.7

26.14

4863

41472

(3015736) pH of Urine

5582

48264

1.25

34.30

3.6

3.0

—

5.9

—

(3030366) Cystatin C [Mass/volume] in Serum or Plasma

436

2333

1.89

33.50

3.7

2.9

mg/l

1.5

1.3

4.45

413

2180

(3018677) aPTT in Platelet poor plasma by Coagulation assay

1804

13475

1.38

33.19

2.2

2.0

28.8

29.2

2.06

1733

13037

(3006140) Bilirubin.total [Moles/volume] in Serum or Plasma

6474

57026

1.23

33.11

5.3

umol/l

9.4

9.6

0.90

6094

53741

(3019497) Choriogonadotropin.beta subunit free [Moles/volume] in Serum or Plasma

328

1603

2.06

32.73

1.2

1.3

—

(3020564) Creatinine [Moles/volume] in Serum or Plasma

13679

131724

1.46

32.20

13.3

11.1

umol/l

67.5

66.3

6.13

13673

131660

(3017918) Cytomegalovirus IgG Ab [Titer] in Serum or Plasma

475

2673

1.80

31.07

1.5

1.3

—

(3015024) Glucose [Moles/volume] in Serum or Plasma --1 hour post dose glucose

465

2611

1.80

30.64

1.6

mmol/l

7.5

0.08

286

1568

(3016771) Amylase [Enzymatic activity/volume] in Serum or Plasma

4192

35447

1.25

30.50

2.7

2.4

u/l

55.7

56.6

0.18

3926

32804

(3015635) Cytomegalovirus IgM Ab [Units/volume] in Serum or Plasma

468

2657

1.78

29.72

1.5

1.3

u/ml

15.2

19.9

—

(3010130) Cytomegalovirus IgG Ab [Units/volume] in Serum or Plasma

440

2486

1.79

28.41

1.5

1.3

u/ml

118.0

109.8

0.47

120

575

(3006923) Alanine aminotransferase [Enzymatic activity/volume] in Serum or Plasma

13787

133295

1.45

28.34

10.3

8.7

u/l

25.1

23.9

7.38

13458

129524

(3035995) Alkaline phosphatase [Enzymatic activity/volume] in Serum or Plasma

9616

89001

1.22

27.80

7.2

6.7

u/l

75.5

73.1

5.32

9118

84081

(3044640) Blood type and Crossmatch panel - Blood

4512

38804

1.23

27.39

2.1

2.0

—

(3019150) Specific gravity of Urine by Refractometry

3224

26786

1.26

26.72

4.2

3.5

kg/l

1.0

0.17

551

4094

(3007853) Bacteria identified in Skin by Aerobe culture

1736

13420

1.33

25.07

1.8

1.6

—

(3003458) Phosphate [Moles/volume] in Serum or Plasma

1480

11206

1.35

24.56

6.6

4.8

mmol/l

1.1

1.0

1.61

1396

10524

(3015399) Transferrin receptor.soluble [Mass/volume] in Serum or Plasma

3391

28560

1.24

24.52

2.3

2.1

mg/l

2.8

2.7

2.31

2974

24618

(3036489) Thrombin time

703

4654

1.53

24.36

2.1

1.9

20.9

20.8

0.24

587

3869

(3003694) ABO and Rh group [Type] in Blood

4867

42637

1.21

23.62

1.9

1.7

—

(3007220) Creatine kinase [Enzymatic activity/volume] in Serum or Plasma

3407

28862

1.23

23.09

2.0

u/l

141.0

141.5

0.02

3223

27226

(3000850) Epithelial cells [#/volume] in Urine

2611

21519

1.25

22.70

2.7

2.3

e6/l

8.5

8.4

0.13

2251

18591

(3029187) Natriuretic peptide.B prohormone N-Terminal [Mass/volume] in Serum or Plasma

2381

19455

1.26

22.25

2.6

2.4

ng/l

788.1

646.5

1.12

1972

15915

(3023368) Bacteria identified in Blood by Culture

2698

22417

1.24

21.72

3.8

3.7

—

(3019250) Coagulation factor VIII activity actual/normal in Platelet poor plasma by Coagulation assay

587

3848

1.54

21.29

2.5

2.3

176.4

168.1

1.51

549

3627

(3004410) Hemoglobin A1c/Hemoglobin.total in Blood

11176

106005

1.21

20.81

5.6

4.3

mmol/mol

39.3

37.5

69.59

10595

100034

(3020779) Urea [Moles/volume] in Serum or Plasma

870

6211

1.42

20.54

9.5

6.8

mmol/l

8.4

7.3

5.15

844

5976

(3013721) Aspartate aminotransferase [Enzymatic activity/volume] in Serum or Plasma

4685

41314

1.19

20.36

3.1

3.0

u/l

33.3

29.1

1.10

4448

39465

(3000515) Antithrombin actual/normal in Platelet poor plasma by Chromogenic method

606

4047

1.51

20.18

2.2

2.0

93.1

95.6

1.71

558

3680

(3013707) Erythrocyte sedimentation rate by Westergren method

9879

92768

1.19

20.09

4.1

3.8

mm/h

11.2

10.1

15.21

9343

87234

(3013512) EKG study

3137

26676

1.22

20.03

3.3

2.9

—

(3016431) Calcium.ionized [Moles/volume] adjusted to pH 7.4 in Serum or Plasma

5664

50833

1.18

19.92

6.7

5.5

mmol/l

1.2

3.44

4731

43087

(3004775) Volume in Urine collected for unspecified duration

120

477

2.52

19.75

2.7

2.2

628.3

617.1

0.12

377

(3014959) Toxoplasma gondii IgG Ab [Units/volume] in Serum

342

2001

1.72

19.66

2.5

2.6

—

(3019902) Methicillin resistant Staphylococcus aureus [Presence] in Specimen by Organism specific culture

1250

9539

1.34

19.52

2.8

2.7

—

(3016750) Collection duration of Urine

101

372

2.72

19.38

2.6

2.1

min

503.2

505.0

0.07

314

(3026782) Osmolality of Urine

2365

19609

1.24

19.14

2.8

2.4

mosm/kgh2o

525.3

519.3

0.58

2043

16613

(3009035) Cobalamin (Vitamin B12) [Moles/volume] in Serum or Plasma

2647

22237

1.23

18.91

1.7

1.6

pmol/l

65442914.7

37969244.2

0.84

2260

19171

(3001122) Ferritin [Mass/volume] in Serum or Plasma

7501

69060

1.17

18.78

3.3

2.9

ug/l

71.7

71.5

0.02

7081

65574

(3021347) Calcium.ionized [Moles/volume] in Serum or Plasma

5085

45417

1.18

18.56

5.9

4.8

mmol/l

1.2

1.43

4676

41403

(3008486) Thyroxine (T4) free [Moles/volume] in Serum or Plasma

11429

108993

1.20

18.34

4.8

4.4

pmol/l

14.4

1.80

10750

102225

(3026515) Parvovirus B19 IgM Ab [Units/volume] in Serum

209

1080

1.94

18.04

1.2

1.3

—

(40761511) CBC panel - Blood by Automated count

13853

135034

1.35

17.80

12.3

9.8

—

(3020460) C reactive protein [Mass/volume] in Serum or Plasma

13160

127484

1.26

17.16

12.2

10.4

mg/l

18.1

18.8

1.66

10676

97709

(3004789) Transferrin [Mass/volume] in Serum or Plasma

1809

14724

1.26

17.12

2.7

2.2

g/l

2.5

0.11

1673

13649

(3009201) Thyrotropin [Units/volume] in Serum or Plasma

12688

122433

1.23

17.03

5.6

5.1

mu/l

1.7

2.0

5.57

12044

115971

(3025159) Blasts/100 leukocytes in Blood

1111

8518

1.33

16.74

4.2

4.1

0.1

0.3

1.27

229

1660

(40764999) Glomerular filtration rate/1.73 sq M.predicted [Volume Rate/Area] in Serum, Plasma or Blood by Creatinine-based formula (CKD-EPI)

12042

115645

1.20

16.70

10.4

9.0

ml/min/173m2

90.1

90.3

0.60

10089

94118

(3017181) Myelocytes/100 leukocytes in Blood

1195

9262

1.31

16.66

4.2

4.0

1.0

0.9

0.13

286

2097

(3044889) 12 lead EKG panel

8279

77189

1.16

16.53

3.1

2.9

—

(3044938) Influenza virus A RNA [Presence] in Specimen by NAA with probe detection

1746

14213

1.26

16.47

1.7

—

(3021440) Promyelocytes/100 leukocytes in Blood

1150

8887

1.31

16.38

4.2

4.0

0.2

0.1

0.11

267

1945

(3002179) Metamyelocytes/100 leukocytes in Blood

1105

8495

1.32

16.33

3.9

3.8

0.7

0.01

210

1523

(3002582) Erythrocytes [#/volume] in Urine

3553

31064

1.19

16.25

3.2

2.7

e6/l

57.8

68.2

0.22

2740

23032

(3027529) Toxoplasma gondii IgM Ab [Units/volume] in Serum

301

1794

1.69

16.25

1.2

1.3

—

(3012095) Magnesium [Moles/volume] in Serum or Plasma

1875

15445

1.24

15.88

3.3

3.1

mmol/l

0.8

5.01

1772

14433

(40763571) Iron/Transferrin [Ratio] in Serum or Plasma

1624

13188

1.26

15.60

2.9

2.3

23.1

23.5

0.54

1385

11427

(3021589) Normoblasts [#/volume] in Blood

5995

54749

1.15

15.52

9.0

8.0

e9/l

0.0

0.10

5120

44917

(3009343) pH of Capillary blood

641

4574

1.42

15.20

3.2

2.8

7.4

0.57

101

621

(3012544) pH of Venous blood

899

6782

1.34

15.13

4.9

3.6

7.4

—

(3009550) Parvovirus B19 IgG Ab [Titer] in Serum

185

977

1.90

15.05

1.3

—

(3022217) INR in Platelet poor plasma by Coagulation assay

1167

9140

1.30

15.03

14.9

13.2

inr

1.2

1.1

0.53

202

1546

(46236098) ABO and Rh group [Type] in Blood by Confirmatory method

3285

28704

1.18

14.92

2.1

1.9

—

(3023024) Carbon dioxide [Partial pressure] in Capillary blood

645

4633

1.41

14.73

3.2

2.8

kpa

5.2

5.1

1.28

610

4304

(3021447) Carbon dioxide [Partial pressure] in Venous blood

869

6571

1.34

14.40

5.0

3.6

kpa

5.9

5.8

0.40

844

6365

(3034603) RHD gene allele [Genotype] in Blood or Tissue by Molecular genetics method Nominal

384

2507

1.54

14.30

1.5

—

(3022948) Iron [Moles/volume] in Serum or Plasma

1962

16407

1.22

14.30

2.7

2.2

umol/l

13.8

14.3

3.16

1827

15251

(43055554) Base excess.100% oxygenated [Moles/volume] standard in Capillary blood by calculation

614

4416

1.40

13.93

3.2

2.7

mmol/l

1.5

0.04

451

3167

(3005785) Creatine kinase.MB [Mass/volume] in Serum or Plasma

728

5402

1.36

13.66

2.1

2.0

ug/l

4.8

5.7

0.85

648

4696

(4146454)

144

723

2.00

13.63

2.9

2.7

—

(3002032) Base excess in Venous blood by calculation

859

6540

1.33

13.59

5.3

3.6

mmol/l

1.7

1.9

0.58

704

5331

(3016502) Oxygen saturation in Arterial blood

941

7259

1.31

13.56

7.3

7.2

96.3

0.06

898

6965

(3023520) Reticulocytes [#/volume] in Blood

781

5871

1.34

13.47

2.6

2.5

e9/l

73.7

71.8

0.67

590

4236

(3026250) Tacrolimus [Mass/volume] in Blood

385

2.37

13.25

44.0

34.6

ug/l

7.3

7.4

0.14

354

(3030467) Casts [#/volume] in Urine by Automated count

3221

28366

1.17

13.02

3.1

2.7

e6/l

0.3

0.63

2476

20615

(3020148) Glutamate decarboxylase 65 Ab [Units/volume] in Serum

294

1849

1.60

12.93

1.1

iu/ml

77.3

5884.5

0.63

458

(3012413) Glucose [Moles/volume] in Serum or Plasma --2 hours post meal

278

1725

1.62

12.93

1.5

mmol/l

10.6

10.9

0.15

229

(3002173) Hemoglobin [Mass/volume] in Arterial blood

897

6921

1.31

12.91

7.8

7.5

g/l

119.2

120.5

1.22

851

6659

(3019145) Choriogonadotropin.beta subunit free [Mass/volume] in Serum or Plasma

1271

10261

1.26

12.77

1.5

—

(3007080) Epstein Barr virus nuclear IgG Ab [Units/volume] in Serum

385

2580

1.50

12.74

1.3

1.2

u/ml

276.9

265.2

0.37

282

1706

(3007844) Epstein Barr virus capsid IgM Ab [Units/volume] in Serum by Immunoassay

405

2743

1.49

12.72

1.2

—

(40759040) C peptide [Moles/volume] in Serum or Plasma --post meal

152

799

1.91

12.63

1.5

1.4

nmol/l

1.6

1.5

0.41

139

717

(3010421) pH of Blood

339

2219

1.54

12.53

3.2

2.8

7.4

0.28

285

1852

(3011960) Natriuretic peptide B [Mass/volume] in Serum or Plasma

722

5426

1.34

12.49

2.4

ng/l

133.3

111.7

0.85

636

4877

(3048816) Calcium.ionized [Moles/volume] adjusted to pH 7.4 in Blood

1026

8094

1.28

12.48

3.5

3.1

mmol/l

1.2

0.06

899

7064

(1616796) Gas panel - Central venous blood

291

1848

1.58

12.31

3.4

2.7

—

(3020630) Protein [Mass/volume] in Serum or Plasma

804

6151

1.32

12.30

2.4

2.3

g/l

66.7

67.3

1.23

742

5673

(3012501) Base excess in Blood by calculation

295

1884

1.57

12.18

3.2

2.9

mmol/l

2.2

2.4

0.61

173

1197

(3013290) Carbon dioxide [Partial pressure] in Blood

295

1884

1.57

12.18

3.2

2.9

kpa

4.9

5.0

1.56

285

1852

(40768446) Kidney Pathology biopsy report

328

2.41

12.03

2.0

1.6

—

(3008152) Bicarbonate [Moles/volume] in Arterial blood

618

4563

1.37

12.00

6.1

6.4

mmol/l

24.4

24.5

0.21

566

4221

(3037522) Nuclear Ab [Titer] in Serum

2387

20642

1.18

11.95

1.4

titre

548.9

571.6

0.23

497

4250

(3029396) Erythrocyte agglutination [Presence] in Blood

161

879

1.84

11.92

3.4

3.1

—

(3027315) Oxygen [Partial pressure] in Blood

296

1902

1.56

11.91

3.2

3.0

kpa

9.1

9.0

0.74

286

1870

(3018658) Beta 2 glycoprotein 1 IgG Ab [Units/volume] in Serum

160

874

1.83

11.83

1.3

1.1

u/ml

28.7

11.0

0.42

(3019050) Tissue transglutaminase IgA Ab [Units/volume] in Serum

3942

35463

1.15

11.74

1.3

u/ml

1.4

1.5

0.09

1235

10259

(3019060) Gas panel - Arterial blood

618

4581

1.36

11.71

4.2

4.6

—

(3027273) Bicarbonate [Moles/volume] in Venous blood

462

3267

1.42

11.60

3.7

3.0

mmol/l

25.3

25.4

0.24

447

3158

(3024354) Oxygen [Partial pressure] in Venous blood

697

5288

1.33

11.33

4.1

3.0

kpa

4.6

4.7

0.15

679

5106

(3004119) Hemoglobin [Mass/volume] in Venous blood

578

4264

1.37

11.31

4.3

3.1

g/l

126.6

129.8

2.88

562

4162

(3000991) Gas panel - Venous blood

804

6227

1.30

11.27

9.9

7.9

—

(3011985) Renin [Units/volume] in Plasma

249

1562

1.60

11.14

1.8

1.7

mu/l

56.1

52.9

0.08

220

1421

(3015235) Bicarbonate [Moles/volume] in Capillary blood

285

1845

1.55

11.13

2.8

2.6

mmol/l

24.3

24.6

0.77

260

1621

(3027801) Oxygen [Partial pressure] in Arterial blood

1045

8380

1.26

11.11

7.3

6.7

kpa

13.3

13.6

0.73

996

8010

(3027946) Carbon dioxide [Partial pressure] in Arterial blood

1044

8385

1.26

10.96

7.3

6.7

kpa

5.0

0.65

998

8019

(3007461) Platelets [#/volume] in Blood

14514

143265

1.49

10.92

18.8

15.8

e9/l

267.5

268.9

1.90

14320

140541

(3012565) Volume of 24 hour Urine

101

485

2.08

10.90

2.2

1.9

1878.9

1987.3

0.52

452

(3024403) Complement+Immunoglobulin [Units/volume] in Red Blood Cells

243

1529

1.59

10.75

1.5

1.6

—

(3041942) Cyclic citrullinated peptide Ab [Units/volume] in Serum

2914

25805

1.16

10.67

1.3

u/ml

8.7

10.2

0.62

1278

10865

(3035941) MCH [Entitic mass]

14521

143375

1.49

10.60

18.7

15.7

29.9

30.0

8.62

14418

142058

(3000963) Hemoglobin [Mass/volume] in Blood

14527

143453

1.49

10.52

18.9

15.8

g/l

132.5

133.0

7.25

14423

142145

(3042936) Bacteria identified in Isolate by Culture

1684

14275

1.20

10.49

2.1

1.8

—

(3017044) Thyrotropin receptor Ab [Units/volume] in Serum

584

4367

1.35

10.49

2.0

iu/l

40.7

24.9

0.23

238

1804

(3026361) Erythrocytes [#/volume] in Blood

14522

143404

1.48

10.40

18.8

15.7

e12/l

4.4

0.41

14304

140487

(3014576) Chloride [Moles/volume] in Serum or Plasma

1183

9693

1.24

10.39

7.7

6.5

mmol/l

104.4

104.8

2.47

1159

9509

(3032836) C peptide [Moles/volume] in Serum or Plasma --fasting

282

1851

1.53

10.38

3.6

2.5

nmol/l

0.8

0.9

0.25

232

1576

(3010813) Leukocytes [#/volume] in Blood

14524

143430

1.48

10.38

18.8

15.8

e9/l

6.9

6.6

59.52

14304

140448

(3048929) Epstein Barr virus Ab [Presence] in Serum

658

5016

1.32

10.37

1.3

1.2

—

(3003396) Base excess in Arterial blood by calculation

1039

8397

1.25

10.33

7.3

6.7

mmol/l

0.8

0.9

0.34

797

6439

(3014111) Lactate [Moles/volume] in Serum or Plasma

850

6710

1.28

10.30

8.0

6.5

mmol/l

1.2

0.09

827

6485

(3024731) MCV [Entitic volume]

14520

143394

1.48

10.25

18.7

15.7

90.0

90.3

15.17

14416

142076

(3018251) Fasting glucose [Moles/volume] in Serum or Plasma

12095

117281

1.15

10.08

4.1

3.6

mmol/l

5.8

5.6

40.62

11346

109977

(36304419) Bacteria [Presence] in Urine

3184

28483

1.15

10.03

3.0

2.6

—

(3028679) Herpes simplex virus Ab [Presence] in Serum

169

989

1.71

9.96

1.2

—

(3001788) Aldosterone [Moles/volume] in Serum or Plasma

227

1433

1.59

9.95

1.5

1.4

pmol/l

413.8

355.0

0.42

188

1117

(3025839) Triglyceride [Moles/volume] in Serum or Plasma

3309

29715

1.14

9.82

1.7

1.6

mmol/l

1.4

1.3

3.64

2796

25813

(3027945) Reticulocytes/100 erythrocytes in Blood

1042

8473

1.24

9.81

2.5

1.8

1.7

2.08

928

7544

(3042733) HLA Ab [Presence] in Serum

274

2.37

9.66

5.4

5.0

—

(3018418) pH of Serum or Plasma

3380

30425

1.14

9.65

4.2

3.6

7.4

0.11

743

5703

(3017143) Hepatitis C virus Ab [Presence] in Serum

2247

19661

1.16

9.55

1.7

1.6

—

(40767503) Oxygen content in Capillary blood by calculation

258

1693

1.53

9.55

2.4

2.1

16.9

16.8

0.12

136

827

(3010937) Rubella virus Ab [Presence] in Serum

139

2.95

9.37

1.1

—

(3046279) Procalcitonin [Mass/volume] in Serum or Plasma

351

2459

1.43

9.37

1.9

2.0

ug/l

1.8

1.9

0.04

312

2190

(4034850)

502

3738

1.35

9.31

9.0

7.5

—

(3041365) Herpes simplex virus IgG Ab [Units/volume] in Serum by Immunoassay

237

2.45

9.25

1.1

—

(46236952) Glomerular filtration rate/1.73 sq M.predicted [Volume Rate/Area] in Serum, Plasma or Blood by Creatinine-based formula (MDRD)

1038

8493

1.24

9.24

2.8

2.3

ml/min/173m2

69.8

75.7

4.23

391

3154

(3042206) Streptococcus agalactiae Ag [Presence] in Vaginal fluid

568

4313

1.33

9.24

1.2

—

(3036481) Cortisol [Moles/volume] in Serum or Plasma

1462

12386

1.20

9.14

2.0

2.1

nmol/l

360.8

377.0

2.70

1343

11432

(3038288) Influenza virus B RNA [Presence] in Specimen by NAA with probe detection

1133

9373

1.22

9.07

1.5

1.6

—

(3043924) Respiratory syncytial virus RNA [Identifier] in Specimen by NAA with probe detection

1117

9238

1.22

8.97

1.5

1.6

—

(40763091) Bacteria identified in Peritoneal dialysis fluid by Culture

6.24

8.95

3.8

2.3

—

(3010566) Parathyrin.intact [Moles/volume] in Serum or Plasma

322

2240

1.44

8.95

3.2

2.3

—

(3010517) Carboxyhemoglobin/Hemoglobin.total in Venous blood

446

3282

1.37

8.94

4.3

3.0

1.3

1.4

0.83

446

3257

(36033641) SARS-CoV-2 (COVID-19) Ag [Presence] in Upper respiratory specimen by Rapid immunoassay

401

2906

1.39

8.84

1.9

1.7

—

(3000067) Parathyrin.intact [Mass/volume] in Serum or Plasma

885

7154

1.25

8.81

4.5

3.3

ng/l

88.0

75.6

3.30

769

6335

(3041145) Herpes simplex virus IgM Ab [Presence] in Serum by Immunoassay

177

1086

1.63

8.78

1.2

—

(3019601) Blood group antibody investigation [Interpretation] in Plasma or RBC

205

1305

1.57

8.73

1.9

1.6

—

(3021614) Rheumatoid factor [Units/volume] in Serum or Plasma

3005

27014

1.14

8.63

1.3

iu/ml

27.8

30.8

0.40

945

8504

(3024889) Methemoglobin/Hemoglobin.total in Venous blood

436

3217

1.36

8.61

4.3

2.9

0.7

0.17

417

3087

(3023081) Carboxyhemoglobin/Hemoglobin.total in Blood

408

2982

1.37

8.56

3.9

4.5

1.7

0.48

378

2772

(3024135) Streptococcus.beta-hemolytic [Presence] in Throat by Organism specific culture

4050

37095

1.12

8.56

1.7

—

(3022493) Free Hemoglobin [Mass/volume] in Plasma

348

2.13

8.53

2.3

3.6

mg/l

2792.6

3173.5

0.05

256

(3022313) Gas panel - Capillary blood

428

3161

1.36

8.41

3.3

2.9

—

(3016293) Bicarbonate [Moles/volume] in Serum or Plasma

619

4824

1.29

8.35

6.3

6.2

mmol/l

24.4

24.7

1.10

610

4789

(40760892) CBC W Ordered Manual Differential panel - Blood

3443

31273

1.13

8.34

4.5

3.9

—

(3023511) Choriogonadotropin [Units/volume] in Urine

827

6677

1.25

8.33

1.4

1.3

—

(3019309) Folate [Moles/volume] in Red Blood Cells

1830

15922

1.17

8.31

1.8

1.7

nmol/l

1230.5

1178.0

1.54

1474

12456

(40758990) Choriogonadotropin.beta subunit [Mass/volume] in Serum or Plasma

114

630

1.81

8.27

1.2

—

(3021337) Troponin I.cardiac [Mass/volume] in Serum or Plasma

1950

17062

1.16

8.22

2.9

ng/l

341.4

284.3

0.32

1076

9409

(3004588) Protein electrophoresis panel - Serum or Plasma

620

4844

1.29

8.21

2.0

2.1

—

(3018095) Leukocytes [#/volume] in Urine

4316

39751

1.12

8.20

3.7

3.2

e6/l

94.1

76.4

0.88

3013

25645

(3020891) Body temperature

394

2886

1.37

8.17

5.1

4.3

—

(36305247) Microscopic observation [Identifier] in Isolate by Gram stain

357

2574

1.39

8.15

1.7

1.6

—

(40762366) Oxygen capacity [Volume Fraction] in Arterial blood

521

3986

1.31

8.08

9.0

8.7

—

(3020491) Glucose [Moles/volume] in Blood

156

949

1.65

8.04

1.6

mmol/l

5.8

6.0

0.59

126

729

(3036525) Urea [Moles/time] in 24 hour Urine

6.49

8.03

1.7

2.3

—

(40760109) Toxoplasma gondii IgG Ab avidity [Ratio] in Serum by Immunoassay

106

581

1.83

7.92

1.2

—

(3027923) C peptide [Moles/volume] in Serum or Plasma

510

1.88

7.91

2.0

2.1

nmol/l

1.4

1.3

0.06

425

(3023150) Myeloperoxidase Ab [Units/volume] in Serum

233

1561

1.50

7.90

1.4

—

(3002109) Cholesterol in LDL/Cholesterol in HDL [Mass Ratio] in Serum or Plasma

1354

15726

0.84

7.86

1.6

1.5

—

(3029856) Leukocytes [#/volume] in Peritoneal dialysis fluid

4.85

7.84

6.2

9.7

e6/l

56.4

793.6

0.92

(3048518) aPTT.lupus sensitive actual/normal (normalized LA screen)

174

1098

1.59

7.75

1.2

1.1

ratio

1.0

1.1

0.65

407

(3034770) Mitochondria Ab [Titer] in Serum

453

3424

1.33

7.67

1.2

1.3

titre

762.6

863.3

0.20

132

(3018921) Toxoplasma gondii IgA Ab [Units/volume] in Serum

101

551

1.83

7.67

1.2

—

(21492711) Cytomegalovirus IgG Ab avidity [Presence] in Serum or Plasma by Immunoassay

133

787

1.69

7.64

1.3

1.2

—

(3042602) Urea [Moles/volume] in Serum or Plasma --post dialysis

101

3.07

7.64

10.1

10.5

mmol/l

4.4

5.0

0.95

101

(3007930) Methemoglobin/Hemoglobin.total in Blood

397

2950

1.35

7.55

3.9

4.6

0.9

0.03

368

2751

(3022621) pH of Urine by Test strip

952

7890

1.22

7.51

3.1

2.6

—

(21494890) Protein electrophoresis panel - 24 hour Urine

108

607

1.78

7.46

1.7

2.0

—

(3026989) Triiodothyronine (T3) Free [Moles/volume] in Serum or Plasma

1306

11158

1.18

7.41

3.6

3.4

pmol/l

4.5

0.22

1182

10049

(3051552) Clostridioides difficile toxin genes [Presence] in Stool by NAA with probe detection

849

6975

1.23

7.31

1.6

—

(3044491) Cholesterol non HDL [Mass/volume] in Serum or Plasma

922

11007

0.82

7.27

1.3

—

(3019225) pH of Specimen

1141

9652

1.19

7.25

3.9

3.5

—

(3049207) Fetal Trisomy 21 risk [Likelihood] Based on maternal age

1146

9701

1.19

7.23

1.5

1.4

—

(3005757) Coagulation factor V activity actual/normal in Platelet poor plasma by Coagulation assay

138

840

1.64

7.15

1.9

1.7

101.5

101.3

0.02

117

750

(3047181) Lactate [Moles/volume] in Blood

367

2721

1.35

7.11

3.9

4.8

mmol/l

1.1

1.2

2.18

319

2407

(3006315) Basophils [#/volume] in Blood

6559

62042

1.10

7.06

5.8

5.6

e9/l

0.0

1.07

5850

54692

(3017766) Complement C4 [Mass/volume] in Serum or Plasma

568

4479

1.28

7.04

2.4

1.9

g/l

0.2

0.50

538

4263

(3008714) Choriogonadotropin [Multiple of the median] adjusted in Serum or Plasma

1140

9671

1.19

7.02

1.5

1.4

—

(3008116) Ketones [Moles/volume] in Urine by Test strip

187

2.40

7.01

1.5

1.4

—

(42870588) Differential panel, method unspecified - Blood

4261

39480

1.11

7.01

5.8

—

(3000504) BK virus DNA [Units/volume] (viral load) in Serum or Plasma by NAA with probe detection

146

2.60

6.97

5.2

6.0

—

(3021960) Folate [Moles/volume] in Serum or Plasma

2475

22249

1.13

6.97

1.5

1.4

nmol/l

20.5

21.3

2.10

2184

19570

(46235831) Pregnancy associated plasma protein A [Multiple of the median] adjusted in Serum or Plasma

1145

9727

1.19

6.94

1.5

1.4

—

(3045424) Erythrocytes [Presence] in Urine

296

2134

1.39

6.84

1.6

1.5

—

(3018461) Alpha 1 globulin [Mass/time] in 24 hour Urine by Electrophoresis

136

2.64

6.83

6.6

4.4

ug/min

20.6

37.7

1.92

(3014007) Fractional oxyhemoglobin in Arterial blood

570

4515

1.27

6.82

9.6

8.7

94.1

94.3

0.27

570

4496

(40763531) Fetal Nuchal fold [Multiple of the median] Thickness adjusted for maternal weight

1144

9733

1.19

6.82

1.5

1.4

—

(3000620) Complement C3 [Mass/volume] in Serum or Plasma

580

4609

1.27

6.76

2.4

1.8

g/l

1.2

0.30

554

4396

(3016701) Glucose [Moles/volume] in Serum or Plasma --2 hours post dose glucose

352

2617

1.35

6.72

1.6

1.5

mmol/l

6.4

6.7

1.76

266

1880

(3020287) Protein C actual/normal in Platelet poor plasma by Coagulation assay

314

2295

1.37

6.69

1.1

123.5

120.6

0.90

283

2083

(3012220) Varicella zoster virus IgM Ab [Presence] in Serum by Immunoassay

331

2443

1.36

6.63

1.1

—

(3001604) Monocytes [#/volume] in Blood

6523

61828

1.09

6.52

5.7

5.6

e9/l

0.5

0.87

5838

54616

(3006184) Hemoglobin [Mass/volume] in Capillary blood

275

1975

1.40

6.52

2.5

1.9

g/l

130.4

130.9

0.14

224

1424

(3016244) Insulin [Units/volume] in Serum or Plasma

181

1204

1.51

6.45

3.8

3.3

mu/l

26.9

28.6

0.28

172

1152

(3000034) Microalbumin [Mass/volume] in Urine

128

787

1.63

6.43

3.1

2.7

mg/l

150.6

43.0

1.56

528

(4306422)

326

2415

1.35

6.39

1.2

—

(3021901) Oxygen saturation in Capillary blood

194

1317

1.48

6.27

2.6

2.4

—

(3014148) Varicella zoster virus Ab [Titer] in Serum

324

2411

1.35

6.19

1.2

—

(3003181) Sodium [Moles/volume] in Urine

180

1208

1.49

6.16

1.4

mmol/l

63.5

64.7

0.14

146

933

(3027238) Thyroperoxidase Ab [Units/volume] in Serum or Plasma

1582

13920

1.15

6.13

1.2

iu/ml

159.1

151.1

0.34

669

5491

(3043409) Potassium [Moles/volume] in Arterial blood

296

2176

1.36

6.12

4.3

4.0

mmol/l

3.8

1.13

282

2041

(3013115) Eosinophils [#/volume] in Blood

6764

64334

1.09

6.10

5.8

e9/l

0.2

7.01

6147

57693

(3005719) IgG [Mass/volume] in Serum or Plasma

1081

9243

1.18

6.10

2.6

g/l

10.6

10.4

1.00

989

8479

(3035544) Cardiolipin IgG Ab [Units/volume] in Serum or Plasma

102

600

1.70

6.09

1.3

1.1

—

(3007821) Glucose [Moles/volume] in Serum or Plasma --baseline

166

1099

1.51

6.07

1.4

1.5

mmol/l

5.2

5.3

0.67

160

1048

(3005353) Prothrombin activity actual/normal in Platelet poor plasma by Coagulation assay

105

627

1.67

5.94

1.1

95.9

96.4

0.06

260

(3008832) Norclozapine [Moles/volume] in Serum or Plasma

822

0.45

5.90

13.2

12.1

nmol/l

628.6

853.6

3.41

797

(3028626) Oxygen [Partial pressure] in Capillary blood

228

1622

1.41

5.77

2.6

2.4

kpa

8.9

8.7

0.56

213

1520

(3028026) IgM [Mass/volume] in Serum or Plasma

840

7062

1.20

5.77

1.7

1.8

g/l

1.4

1.3

0.17

774

6511

(3007628) Bicarbonate [Moles/volume] standard in Venous blood

448

3525

1.28

5.73

6.7

4.1

mmol/l

23.8

24.3

2.33

385

3173

(3007566) Smooth muscle Ab [Titer] in Serum

442

3472

1.28

5.73

1.2

1.3

titre

118.3

147.0

0.29

339

(3005772) Bilirubin.conjugated [Moles/volume] in Serum or Plasma

1466

12901

1.15

5.68

2.4

umol/l

6.4

6.3

0.05

1216

10799

(21494755) Public health laboratory ask at order entry panel

1648

18427

0.88

5.67

1.3

—

(3004490) Bicarbonate [Moles/volume] standard in Capillary blood

371

2855

1.30

5.64

3.5

2.9

mmol/l

24.8

0.09

349

2663

(3009041) Cardiolipin IgG Ab [Units/volume] in Serum by Immunoassay

321

2421

1.33

5.64

1.3

1.2

u/ml

4.8

3.9

0.55

141

1011

(3022575) Varicella zoster virus IgG Ab [Units/volume] in Serum

124

783

1.58

5.64

1.1

miu/ml

1541.4

1479.7

0.25

124

783

(3002385) Erythrocyte distribution width [Ratio]

11379

110879

1.10

5.64

14.5

12.6

13.5

0.76

11167

108843

(3020427) Coagulation factor X inhibitor [Units/volume] in Platelet poor plasma by Coagulation assay

261

1909

1.37

5.61

3.5

3.4

u/ml

0.4

0.28

154

1059

(4198724)

109

670

1.63

5.54

2.5

2.4

—

(3011397) Hemoglobin [Presence] in Urine by Test strip

3117

28716

1.10

5.54

4.0

3.3

—

(3004409) Coagulation factor X activity actual/normal in Platelet poor plasma by Coagulation assay

101

612

1.65

5.44

1.1

100.2

100.3

0.01

256

(3033306) Mononuclear cells/100 leukocytes in Cerebral spinal fluid

109

676

1.61

5.36

1.2

1.3

50.9

70.3

1.04

(3019198) Lymphocytes [#/volume] in Blood

6725

64165

1.08

5.35

5.8

5.6

e9/l

2.0

0.70

6114

57783

(3002434) Lupus erythematosus deoxynucleoproteins IgG Ab [Units/volume] in Serum by Immunoassay

591

4841

1.23

5.33

2.5

2.0

—

(3009445) Proteinase 3 Ab [Units/volume] in Serum

527

4269

1.24

5.28

1.4

1.5

u/ml

4.7

10.2

2.37

105

(46235759) Influenza virus B RNA [Presence] in Nasopharynx by NAA with probe detection

503

4054

1.25

5.28

1.9

2.0

—

(3006504) Eosinophils/100 leukocytes in Blood

6102

58043

1.08

5.19

5.8

5.7

2.9

2.8

2.54

5690

54327

(40761535) Cells panel - Urine sediment

938

8044

1.17

5.14

4.1

3.2

—

(3047169) Lambda light chains.free [Mass/volume] in Serum or Plasma

256

1896

1.35

5.12

3.2

3.1

mg/l

30.0

36.3

0.65

199

1521

(3001019) Free T4 and TSH panel - Serum or Plasma

1060

12134

0.86

5.12

1.7

—

(3019069) Monocytes/100 leukocytes in Blood

6130

58342

1.08

5.12

6.0

5.9

7.8

7.9

4.59

5770

55062

(3006441) Cardiolipin IgM Ab [Presence] in Serum by Immunoassay

608

1.63

5.09

1.2

1.1

—

(3023602) Cholesterol in HDL [Moles/volume] in Serum or Plasma

12383

121319

1.11

5.08

4.0

3.6

mmol/l

1.5

1.6

57.65

11746

114998

(3034860) Kappa light chains.free [Mass/volume] in Serum

256

1899

1.35

5.07

3.2

3.1

mg/l

33.7

69.1

0.62

202

1522

(40760888) Immunoglobulin light chains.free panel - Serum

201

1434

1.40

5.06

3.3

3.2

—

(706163) SARS-CoV-2 (COVID-19) RNA [Presence] in Respiratory system specimen by NAA with probe detection

10918

106354

1.09

5.01

3.9

3.7

—

(3037756) Immunofixation for Serum or Plasma

178

1247

1.43

4.97

1.8

1.7

—

(3011547) Coagulation factor VII activity actual/normal in Platelet poor plasma by Coagulation assay

102

636

1.60

4.95

1.1

115.7

117.7

0.22

567

(3039000) Anion gap in Blood

237

1746

1.36

4.93

4.8

6.0

mmol/l

11.3

11.1

0.35

209

1565

(3018572) Chloride [Moles/volume] in Blood

237

1747

1.36

4.91

4.8

6.0

mmol/l

105.2

105.6

0.50

209

1566

(3030981) Hyaline casts [#/volume] in Urine by Automated count

593

4903

1.21

4.91

2.6

2.4

e6/l

0.2

0.3

1.07

560

4694

(3024471) HLA-A [Type]

295

1.90

4.90

1.0

—

(3044254) Respiratory syncytial virus RNA [Presence] in Specimen by NAA with probe detection

457

3678

1.25

4.89

1.9

—

(3048773) Triglyceride [Moles/volume] in Serum or Plasma --fasting

11917

116598

1.10

4.83

3.7

3.3

mmol/l

1.3

1.2

25.64

11279

110176

(3023183) Ammonium ion [Moles/volume] in Plasma

207

1498

1.38

4.82

3.5

2.9

umol/l

33.5

33.1

0.07

179

1307

(3027505) Alpha-1-Fetoprotein [Units/volume] in Amniotic fluid

3.78

4.78

1.1

1.0

—

(586526) SARS-CoV-2 (COVID-19) RNA [Presence] in Nasopharynx by NAA with probe detection

671

5635

1.20

4.72

1.5

—

(3044355) Beta 2 glycoprotein 1 IgG Ab [Units/volume] in Serum or Plasma by Immunoassay

323

2505

1.29

4.71

1.3

1.2

u/ml

3.4

3.1

0.11

111

821

(3007778) Kappa light chains/Lambda light chains [Mass Ratio] in Serum

246

1837

1.34

4.70

3.1

ratio

1.5

1.8

0.21

187

(3024172) Erythropoietin (EPO) [Units/volume] in Serum or Plasma

148

1014

1.46

4.68

1.3

1.2

u/l

40.1

28.6

0.51

134

893

(3004809) Band form neutrophils/100 leukocytes in Blood

186

1329

1.40

4.68

2.6

2.8

1.5

1.3

0.24

142

1044

(3019900) Cholesterol [Moles/volume] in Serum or Plasma

12438

121997

1.10

4.64

4.1

3.6

mmol/l

4.8

4.9

27.55

11800

115872

(3012477) Bordetella pertussis DNA [Presence] in Specimen by NAA with probe detection

180

1282

1.41

4.62

1.3

—

(40768797) Stomach Pathology biopsy report

1817

16419

1.12

4.62

1.2

—

(3008898) HLA-B27 [Presence]

802

6858

1.18

4.59

1.1

—

(3001308) Cholesterol in LDL [Moles/volume] in Serum or Plasma

12551

123197

1.10

4.50

4.4

3.9

mmol/l

2.9

13.27

11833

116250

(3036669) Protein S actual/normal in Platelet poor plasma by Coagulation assay

117

773

1.51

4.45

1.1

89.0

93.0

0.83

621

(3024932) HLA-DR beta [Type]

284

1.86

4.44

1.1

1.2

—

(3033658) Prothrombin time (PT) actual/Normal

2984

27708

1.09

4.40

3.6

3.3

99.9

98.4

3.05

2847

26859

(3026179) Normetanephrine [Moles/volume] in Serum or Plasma

229

1716

1.34

4.31

1.2

1.3

nmol/l

0.5

1.5

0.72

221

1663

(3000924) Streptococcus pyogenes [Presence] in Throat by Organism specific culture

341

2697

1.27

4.29

1.3

1.2

—

(40761539) Cells [Type] in Urine sediment by Light microscopy

231

1.95

4.29

1.4

1.2

—

(46235128) Lupus anticoagulant aPTT and dRVVT screening panel W Reflex

122

820

1.49

4.29

1.2

—

(3045414) Leukocytes [Presence] in Urine

685

5825

1.18

4.22

1.8

1.7

—

(3007463) Buprenorphine [Presence] in Urine

2.69

4.22

6.0

8.5

—

(3022096) Basophils/100 leukocytes in Blood

5865

56010

1.07

4.21

5.9

5.8

0.7

1.66

5481

52402

(3013742) Prealbumin [Mass/volume] in Serum or Plasma

1019

8936

1.15

4.20

2.3

2.2

g/l

0.2

1.02

956

8430

(3030408) 3-Methoxytyramine [Moles/volume] in Serum or Plasma

228

1715

1.33

4.20

1.2

1.3

nmol/l

0.2

—

(3020229) Cytomegalovirus DNA [Presence] in Specimen by NAA with probe detection

226

1.94

4.20

1.1

1.2

—

(43055120) Cytomegalovirus DNA [Units/volume] (viral load) in Serum or Plasma by NAA with probe detection

262

2013

1.30

4.15

6.8

5.1

iu/ml

1112.6

893.1

0.18

255

(3004280) Aldosterone [Moles/volume] in Serum or Plasma --supine

4.07

4.14

1.0

pmol/l

354.0

173.8

—

(3015147) Influenza virus A IgG Ab [Units/volume] in Serum

4.07

4.14

1.3

1.0

—

(40770918) von Willebrand factor (vWf).activity actual/normal in Platelet poor plasma by Immunoassay

124

844

1.47

4.11

1.5

1.7

119.5

123.4

0.28

116

789

(3003985) Beta hydroxybutyrate [Moles/volume] in Serum or Plasma

109

2.38

4.10

2.2

3.7

mmol/l

0.8

1.1

0.40

(3037441) Creatinine [Moles/volume] in Peritoneal dialysis fluid

4.34

4.07

6.0

5.6

umol/l

347.5

416.1

—

(3006653) Thiamine [Moles/volume] in Blood

613

1.55

4.06

1.5

nmol/l

133.4

132.0

0.12

613

(3051014) Leukocytes [#/area] in Urine sediment by Automated count

112

750

1.49

4.03

1.7

1.8

u/field

1.8

2.5

1.00

383

(3002030) Lymphocytes/100 leukocytes in Blood

6324

60645

1.07

3.95

5.8

5.7

29.4

29.8

3.16

5913

56980

(3003284) Neutrophil cytoplasmic Ab.perinuclear [Titer] in Serum by Immunofluorescence

425

3483

1.22

3.92

1.6

titre

474.1

291.8

0.46

155

(3003338) MCHC [Mass/volume]

11258

114331

0.93

3.89

15.5

13.2

g/l

331.9

331.7

1.95

11189

113558

(3030862) Granulocytes [#/volume] in Cerebral spinal fluid

394

1.67

3.88

1.2

30.7

19.9

—

(3015171) Extractable nuclear Ab [Units/volume] in Serum

757

6538

1.16

3.87

1.3

u/ml

0.5

1.1

1.86

540

(3015816) F5 gene p.Arg506Gln [Presence] in Blood or Tissue by Molecular genetics method

300

2375

1.27

3.80

1.1

—

(3043849) Epstein Barr virus DNA [Units/volume] (viral load) in Serum or Plasma by NAA with probe detection

201

1514

1.33

3.72

2.9

2.4

u/ml

215.6

11778.2

—

(43054903) Holo-transcobalamin II [Moles/volume] in Serum

4447

42216

1.07

3.66

1.9

1.8

pmol/l

98.8

100.1

1.15

2420

21976

(3018010) Neutrophils/100 leukocytes in Blood

6236

59876

1.07

3.66

5.6

5.5

56.8

56.3

3.22

5853

56450

(3013650) Neutrophils [#/volume] in Blood by Automated count

7380

71258

1.07

3.62

7.9

8.4

e9/l

4.1

3.9

10.81

6618

62919

(4268621)

219

1677

1.31

3.61

2.4

2.3

—

(3016038) Potassium [Moles/volume] in Urine

465

1.59

3.59

1.3

mmol/l

28.1

33.9

2.02

405

(3020629) Protein S Free Ag actual/normal in Platelet poor plasma by Immunoassay

214

1636

1.31

3.58

1.1

92.2

93.6

0.37

201

1538

(3032155) Metanephrine Free [Moles/volume] in Serum or Plasma

204

1558

1.31

3.45

1.2

—

(36660697) Celiac disease serology panel - Serum

1387

12556

1.11

3.44

1.2

—

(3033926) Protein [Mass/volume] in Peritoneal dialysis fluid

5.70

3.33

7.4

3.8

g/l

1.8

1.4

—

(3044009) aPTT.lupus sensitive (LA screen)

161

1.98

3.30

1.3

1.2

—

(3007164) IgA [Mass/volume] in Serum or Plasma

3160

29729

1.08

3.30

1.4

g/l

2.2

2.1

1.73

2023

18780

(3005136) Cladosporium herbarum IgE Ab [Units/volume] in Serum

184

2390

0.76

3.26

1.0

u/ml

0.3

0.04

455

(3017732) Neutrophils [#/volume] in Blood

1053

9433

1.12

3.17

2.1

2.4

e9/l

4.2

4.1

0.74

869

7832

(3039429) Cortisol [Moles/volume] in Saliva (oral fluid)

102

708

1.44

3.15

1.4

1.7

nmol/l

2.2

10.2

0.55

584

(3004451) EKG impression Narrative

280

1.71

3.14

1.2

—

(3000330) Specific gravity of Urine by Test strip

566

4868

1.17

3.12

3.1

2.8

—

(3023430) Cat dander IgE Ab [Units/volume] in Serum

222

2797

0.79

3.11

1.1

u/ml

4.1

4.9

0.33

1123

(3019174) dRVVT (LA screen)

158

1.96

3.10

1.2

—

(3037556) Urate [Mass/volume] in Serum or Plasma

223

1.79

3.06

1.2

—

(3012568) Campylobacter sp identified in Specimen by Organism specific culture

191

1473

1.30

3.06

1.3

1.4

—

(40766189) Gliadin peptide IgG Ab [Units/volume] in Serum by Immunoassay

569

4910

1.16

3.02

1.1

u/ml

8.1

4.3

0.54

782

(3008909) Norovirus RNA [Presence] in Stool by NAA with probe detection

279

2257

1.24

3.01

1.2

—

(3041806) Other cells [#/volume] in Blood by Manual count

890

0.64

2.96

1.5

—

(3041067) Sjogrens syndrome-A extractable nuclear 52kD Ab [Units/volume] in Serum

143

1067

1.34

2.91

1.3

1.2

u/ml

52.2

45.6

—

(1175825) Sexually transmitted pathogens panel - Specimen by NAA with probe detection

108

2.13

2.87

1.0

1.4

—

(1761482) Bacteria [#/volume] in Urine by Culture

241

1930

1.25

2.87

3.5

—

(3002482) Mycoplasma pneumoniae DNA [Presence] in Specimen by NAA with probe detection

198

1549

1.28

2.86

1.3

1.4

—

(40763641) Cell count and Differential panel - Peritoneal dialysis fluid

6.65

2.86

6.7

2.0

—

(3011648) Oxygen content in Venous blood

616

1.44

2.83

3.6

2.3

11.1

11.2

0.10

616

(3001186) Copper [Moles/volume] in Serum or Plasma

344

1.60

2.80

1.4

1.5

umol/l

17.4

17.6

0.15

304

(3043238) Trisomy 21 risk [Likelihood] in Fetus

911

8158

1.12

2.80

1.6

1.5

—

(3005229) Alpha 2 globulin [Mass/volume] in Serum or Plasma by Electrophoresis

331

2748

1.21

2.79

2.3

2.0

g/l

7.2

0.01

247

2136

(3041423) Sjogrens syndrome-A extractable nuclear 60kD Ab [Units/volume] in Serum

142

1066

1.33

2.79

1.3

1.2

u/ml

64.4

58.4

—

(37019628) Gastrointestinal bacterial pathogens panel - Stool by NAA with probe detection

309

2550

1.21

2.78

1.3

1.4

—

(40766048) U1 small nuclear ribonucleoprotein 70kD Ab [Units/volume] in Serum by Immunoassay

137

1025

1.34

2.76

1.2

u/ml

2.3

6.8

—

(3006588) Cancer Ag 15-3 [Units/volume] in Serum or Plasma

227

2809

0.80

2.76

3.7

3.6

u/ml

39.5

31.8

0.28

219

2702

(3021197) Magnesium Ionized [Moles/volume] in Serum or Plasma

369

1.57

2.76

2.5

2.8

—

(3043723) Beta 1 globulin [Mass/volume] in Serum or Plasma by Electrophoresis

330

2744

1.20

2.75

2.3

2.0

—

(3043747) Beta 2 globulin [Mass/volume] in Serum or Plasma by Electrophoresis

330

2744

1.20

2.75

2.3

2.0

g/l

3.6

3.7

0.85

229

2018

(42868544) Hantavirus puumala IgM Ab [Presence] in Serum or Plasma by Immunofluorescence

201

1585

1.27

2.74

1.2

1.1

—

(3010726) Horse dander IgE Ab [Units/volume] in Serum

279

3376

0.82

2.74

1.1

u/ml

1.5

2.0

0.32

815

(37021550) Renin [Units/volume] in Plasma --upright

233

1.71

2.68

1.4

1.3

mu/l

37.6

76.4

1.99

186

(3003888) Timothy IgE Ab [Units/volume] in Serum

294

3531

0.83

2.68

1.1

u/ml

3.6

5.0

0.95

142

1768

(3025468) Yersinia sp identified in Specimen by Organism specific culture

182

1424

1.28

2.66

1.3

1.4

—

(3048689) Calprotectin [Mass/mass] in Stool

2108

19690

1.08

2.66

2.5

2.3

ug/g

104.5

101.1

0.20

1692

15277

(3034092) Cytoplasmic Ig cells/100 cells in Blood

182

1.81

2.66

4.5

6.1

—

(21493466) Plesiomonas shigelloides DNA [Presence] in Stool by NAA with non-probe detection

182

1425

1.28

2.65

1.3

1.4

—

(3017354) Segmented neutrophils/100 leukocytes in Blood

111

810

1.37

2.64

2.4

2.7

58.6

55.6

0.60

520

(3021952) Alkaline phosphatase isoenzymes [Enzymatic activity/volume] in Serum or Plasma by Heat stability

226

1816

1.24

2.64

1.3

—

(3020565) Legionella pneumophila DNA [Presence] in Specimen by NAA with probe detection

137

1033

1.33

2.63

1.3

—

(3028707) Methadone [Presence] in Urine by Screen method

387

3279

1.18

2.63

3.7

2.5

—

(3022689) Creatine [Moles/volume] in Urine

280

1.64

2.63

1.5

—

(3016628) Fibrinogen Ag [Mass/volume] in Platelet poor plasma by Immunoassay

227

1.72

2.63

1.1

1.2

mg/l

0.5

85.8

1.90

163

(21494670) JAK2 gene exon 14 targeted mutation analysis in Blood or Tissue by Molecular genetics method

134

1008

1.33

2.62

1.1

1.0

—

(3019083) Insulin-like growth factor [Moles/volume] in Serum or Plasma

250

1.68

2.61

1.5

1.6

—

(3005988) Vibrio sp identified in Specimen by Organism specific culture

182

1428

1.27

2.61

1.3

1.4

—

(42868716) Shigella species+EIEC invasion plasmid antigen H ipaH gene [Presence] in Stool by NAA with probe detection

184

1447

1.27

2.59

1.3

1.4

—

(4024509)

138

1049

1.31

2.52

1.6

1.5

—

(3015322) Alpha 1 globulin [Mass/volume] in Serum or Plasma by Electrophoresis

316

2643

1.20

2.51

2.3

2.0

g/l

3.0

0.01

240

2091

(3006093) Chlamydia trachomatis DNA [Presence] in Specimen by NAA with probe detection

2109

19745

1.08

2.50

1.8

—

(3029634) Reagin Ab [Titer] in Serum by VDRL

234

1901

1.23

2.49

1.8

1.5

titre

0.6

1.7

—

(3020650) Glucose [Presence] in Urine

387

1.52

2.49

1.2

1.4

—

(3008401) Mugwort IgE Ab [Units/volume] in Serum

279

3335

0.83

2.45

1.1

u/ml

1.4

1.1

0.16

104

1331

(42868674) Cholesterol in HDL/Cholesterol.total [Molar ratio] in Serum or Plasma

1381

12724

1.09

2.44

4.1

3.6

32.5

32.8

0.59

1074

9318

(3036604) Creatine kinase isoenzymes [Interpretation] in Serum or Plasma by Electrophoresis

2.38

2.44

1.1

1.2

—

(3014300) Beta 2 glycoprotein 1 IgM Ab [Units/volume] in Serum

397

1.51

2.44

1.4

1.1

—

(3047189) Immunofixation for 24 hour Urine

263

1.63

2.44

1.6

2.0

—

(3014133) Dog dander IgE Ab [Units/volume] in Serum

244

2951

0.82

2.42

1.0

1.1

u/ml

3.8

4.8

0.51

1093

(3024522) Salmonella sp identified in Specimen by Organism specific culture

182

1443

1.26

2.42

1.3

1.4

—

(36304997) Mycobacterium tuberculosis stimulated gamma interferon release by CD4+ and CD8+ T-cells [Units/volume] in Blood

490

4261

1.15

2.42

1.7

1.6

iu/ml

0.2

5.0

0.61

800

(44816559) Phosphatidylethanol [Mass/volume] in Blood

300

2507

1.20

2.42

1.6

1.3

—

(3040151) Glucose [Moles/volume] in Capillary blood

130

989

1.31

2.39

2.2

5.7

mmol/l

7.5

7.1

0.46

101

800

(3009471) Fatty acids.nonesterified [Moles/volume] in Serum or Plasma

3.33

2.38

5.8

4.2

mmol/l

0.2

—

(40765091) Chromosome analysis panel - Chorionic villus sample by G-banded

124

1.93

2.37

1.0

1.1

—

(3021513) Carbon dioxide [Partial pressure] in Mixed venous blood

124

1.93

2.37

19.3

8.5

—

(3033923) Metanephrine [Moles/time] in 24 hour Urine

227

1.67

2.36

1.1

umol/24h

0.6

0.11

112

(3029536) Hepatitis C virus RNA [Units/volume] (viral load) in Specimen by NAA with probe detection

623

1.40

2.36

1.6

iu/ml

1008500.0

1838070.2

—

(3006598) pH of Arterial cord blood

2.74

2.36

1.1

1.2

—

(44816844) Macroprolactin [Units/volume] in Serum or Plasma

341

2893

1.18

2.33

1.5

1.6

—

(3014064) Pregnancy associated plasma protein A [Multiple of the median] in Serum or Plasma

221

1.67

2.31

1.0

—

(3015377) Calcium [Moles/volume] in Serum or Plasma

3911

37442

1.06

2.30

3.0

3.1

mmol/l

2.3

2.4

2.37

3524

33471

(3003510) Neisseria gonorrhoeae DNA [Presence] in Urine by NAA with probe detection

2791

26461

1.06

2.29

2.0

—

(40771025) 25-Hydroxyvitamin D3+25-Hydroxyvitamin D2 [Moles/volume] in Serum or Plasma

5612

54248

1.05

2.28

2.5

2.3

nmol/l

74.9

1697.6

0.50

5231

50565

(3005895) Myoglobin [Mass/volume] in Serum or Plasma

290

2433

1.19

2.26

2.0

2.1

ug/l

190.2

460.1

1.87

262

2165

(3048402) Erythrocytes [#/area] in Urine sediment by Automated count

595

1.39

2.25

1.5

1.6

u/field

2.6

1.9

0.21

428

(3024928) Oxygen saturation in Venous blood

193

1557

1.24

2.23

5.7

3.5

—

(3017704) Immunofixation for Urine

317

1.54

2.23

1.6

—

(3036086) Jo-1 extractable nuclear Ab [Units/volume] in Serum by Immunoassay

358

3064

1.17

2.21

1.3

1.2

u/ml

29.9

12.6

—

(40760435) Tropomyosin IgE Ab [Units/volume] in Serum

225

1.64

2.17

1.1

1.0

—

(3026285) Alpha 1 antitrypsin [Mass/volume] in Serum or Plasma

188

1518

1.24

2.17

1.1

g/l

1.4

1.5

0.57

174

1379

(3036185) Alkaline phosphatase.liver 2 [Enzymatic activity/volume] in Serum or Plasma

608

1.38

2.17

1.2

1.1

u/l

20.6

18.7

0.15

480

(44806420)

129

1.86

2.14

2.3

2.2

—

(3003329) Lymphocytes/100 leukocytes in Synovial fluid

113

858

1.32

2.14

1.7

1.6

42.1

38.9

0.33

514

(3042194) Human metapneumovirus RNA [Presence] in Specimen by NAA with probe detection

253

2110

1.20

2.13

1.4

1.5

—

(3013784) Calcium.ionized [Moles/volume] in Serum or Plasma by Ion-selective membrane electrode (ISE)

219

1.64

2.12

1.1

1.3

—

(3013327) Hepatitis A virus IgM Ab [Presence] in Serum

245

2039

1.20

2.11

1.1

—

(3020356) Listeria sp identified in Specimen by Organism specific culture

189

1.69

2.10

1.1

1.2

—

(3035062) Alkaline phosphatase.liver 1 [Enzymatic activity/volume] in Serum or Plasma

612

1.37

2.09

1.2

1.1

u/l

81.1

76.7

0.23

497

(3022670) pH of Venous cord blood

2.70

2.09

1.2

1.1

—

(3005033) Fetal Nuchal fold Thickness US

876

7970

1.10

2.07

1.5

1.4

—

(3018006) Microscopic observation [Identifier] in Cervix by Cyto stain.thin prep

4334

41710

1.05

2.07

1.5

—

(3011371) Neisseria gonorrhoeae DNA [Presence] in Specimen by NAA with probe detection

1630

15232

1.08

2.06

1.7

—

(3031478) Chlamydophila pneumoniae DNA [Presence] in Specimen by NAA with probe detection

147

1162

1.26

2.06

1.4

—

(3034614) HLA Ag [Interpretation]

2.90

2.06

1.0

1.1

—

(3004616) Nuclear Ab [Presence] in Serum

218

1800

1.21

2.05

1.4

—

(3015916) Alpha-1-Fetoprotein [Units/volume] in Serum or Plasma

160

1279

1.25

2.04

2.0

u/ml

11.8

1018.2

0.68

138

1125

(3025245) SCL-70 extractable nuclear Ab [Units/volume] in Serum by Immunoassay

370

3198

1.16

2.04

1.3

u/ml

1.1

4.2

2.24

257

(42870365) C reactive protein [Mass/volume] in Blood by High sensitivity method

148

1174

1.26

2.02

2.0

mg/l

26.2

23.1

0.33

320

(3049506) Microalbumin [Mass/time] in Urine collected for unspecified duration

309

1.52

2.02

2.0

ug/min

25.5

70.7

—

(3027456) Digoxin [Moles/volume] in Serum or Plasma

644

1.35

1.98

3.7

3.1

nmol/l

0.8

0.83

486

(3047352) Trisomy 18 risk [Likelihood] in Fetus

875

7983

1.10

1.97

1.5

1.4

—

(3040853) Adenovirus DNA [Identifier] in Specimen by NAA with probe detection

244

2045

1.19

1.97

1.4

1.5

—

(3023465) Gamma globulin [Mass/volume] in Serum or Plasma by Electrophoresis

299

2550

1.17

1.97

2.0

g/l

10.2

10.1

0.21

253

2182

(3020961) Endomysium IgA Ab [Titer] in Serum

896

8185

1.10

1.97

1.1

titre

336.7

178.9

0.45

202

(3044927) Protein electrophoresis panel - Urine

603

1.36

1.95

1.1

1.2

—

(3023351) European house dust mite IgE Ab [Units/volume] in Serum

342

3933

0.86

1.95

1.1

u/ml

2.4

1.3

0.76

113

1467

(3016650) Hepatitis A virus Ab [Presence] in Serum

252

2122

1.19

1.94

1.1

—

(3030306) Epithelial cells.non-squamous [#/volume] in Urine by Automated count

1793

16855

1.07

1.93

2.6

2.3

e6/l

1.2

1.4

0.45

1066

8989

(3015822) Parvovirus B19 DNA [Presence] in Serum by NAA with probe detection

2.44

1.91

1.5

1.1

—

(3029713) Protein.monoclonal band 1 [Mass/volume] in Serum or Plasma by Electrophoresis

277

2357

1.18

1.89

2.2

2.1

g/l

0.4

0.5

0.23

247

2088

(3050898) Methicillin resistant Staphylococcus aureus [Presence] in Genital specimen by Organism specific culture

300

1.50

1.84

2.2

2.4

—

(3001501) Glucose [Moles/volume] in Capillary blood by Glucometer

144

1.73

1.82

2.4

2.2

mmol/l

7.9

6.7

0.68

(40764126) Parainfluenza virus RNA [Presence] in Specimen by NAA with probe detection

585

1.35

1.82

1.4

—

(3006442) Creatine [Moles/volume] in Serum or Plasma

102

784

1.30

1.82

1.4

umol/l

69.2

64.5

—

(3039114) Acanthocytes/1000 erythrocytes in Blood by Light microscopy

4.16

1.82

1.2

—

(43534045) MCM6 gene c.-13910C>T and -13915T>G [Identifier] in Blood or Tissue by Molecular genetics method Nominal

824

8954

0.91

1.80

1.1

—

(3050099) BK virus DNA [#/volume] (viral load) in Specimen by NAA with probe detection

3.04

1.79

5.4

2.7

—

(3022145) Colonoscopy Study observation

1395

13037

1.07

1.79

1.3

—

(3003171) Aldosterone [Moles/volume] in Serum or Plasma --upright

254

1.53

1.78

1.3

1.2

pmol/l

441.2

405.5

0.14

194

(3027953) Aldolase [Enzymatic activity/volume] in Serum or Plasma

752

1.30

1.78

1.4

u/l

5.5

5.3

0.12

625

(3000855) Microscopic observation [Identifier] in Vaginal fluid by Gram stain

377

4273

0.88

1.78

1.5

—

(3046870) Tissue transglutaminase IgG Ab [Units/volume] in Serum

690

6261

1.10

1.77

1.1

u/ml

1.4

9.1

0.87

(3052851) Hemolysis interference index of Serum or Plasma

355

3099

1.15

1.76

2.7

2.6

—

(3029023) Hepatitis E virus IgG Ab [Presence] in Serum by Immunoassay

105

816

1.29

1.74

1.1

—

(3035797) Protein.monoclonal band 2 [Mass/volume] in Serum or Plasma by Electrophoresis

254

2167

1.17

1.71

2.1

2.0

g/l

0.0

1.84

237

1987

(40760848) Basement membrane zone BP180 Ab [Units/volume] in Serum by Immunoassay

532

1.35

1.70

1.4

u/ml

22.3

18.9

0.34

101

(3028334) Neisseria gonorrhoeae [Presence] in Specimen by Organism specific culture

215

0.46

1.69

1.1

—

(1176173) BK virus + JC virus DNA [Presence] in Specimen by NAA with probe detection

2.29

1.69

5.4

3.6

—

(3045783) Sodium and Potassium panel [Moles/volume] - Serum or Plasma

1288

12033

1.07

1.68

6.0

4.9

—

(3019420) Tryptase [Mass/volume] in Serum or Plasma

114

900

1.27

1.68

1.4

ug/l

6.7

7.1

0.21

101

805

(3034037) Hematocrit [Volume Fraction] of Mixed venous blood

2.00

1.68

6.3

6.4

—

(3000492) Spirometry study

1173

12519

0.93

1.67

1.4

—

(3022756) Ceruloplasmin [Mass/volume] in Serum or Plasma

119

945

1.26

1.67

1.1

mg/l

291.1

305.4

1.36

109

836

(4211845)

681

1.31

1.67

3.2

2.7

—

(3048879) Bone marrow aspiration report

156

1.66

1.67

1.2

2.5

—

(3001964) Herpes simplex virus Ag [Presence] in Specimen

417

0.62

1.66

1.7

1.3

—

(3050238) Crystals [Presence] in Synovial fluid by Light microscopy

268

2305

1.16

1.65

1.4

—

(1001509) Gas and Carbon monoxide and Electrolytes panel - Arterial blood

723

0.72

1.63

1.5

1.6

—

(3029790) Creatine kinase.MB [Enzymatic activity/volume] in Serum or Plasma

2.02

1.63

1.1

u/l

7.9

12.1

0.46

(3035637) Corticotropin [Mass/volume] in Plasma

183

1526

1.20

1.62

1.4

1.6

—

(3041449) Collagen crosslinked C-telopeptide [Mass/volume] in Serum or Plasma

269

1.48

1.60

1.5

1.6

ug/l

0.4

0.00

192

(4281824)

144

1748

0.82

1.60

1.1

—

(3006462) Nitrate [Presence] in Urine

616

1.31

1.60

2.9

2.7

—

(3034891) Synovial lining cells/100 cells in Synovial fluid

470

1.36

1.59

1.6

1.5

7.0

4.4

0.47

(3003785) Carcinoembryonic Ag [Mass/volume] in Serum or Plasma

842

9082

0.92

1.59

3.3

3.7

ug/l

15.1

20.9

0.34

604

6655

(3021125) Hepatitis C virus RNA [Presence] in Serum or Plasma by NAA with probe detection

103

810

1.27

1.58

1.4

—

(3048522) Glucose [Moles/volume] in Serum or Plasma --pre dose glucose

262

1.49

1.58

1.7

1.4

—

(3027450) Sjogrens syndrome-B extractable nuclear Ab [Units/volume] in Serum

501

4511

1.11

1.54

1.3

u/ml

31.4

35.7

0.14

320

(3021236) Streptolysin O Ab [Units/volume] in Serum or Plasma

638

1.30

1.53

1.1

iu/ml

147.0

156.3

0.21

633

(3001850) Coagulation factor XI activity actual/normal in Platelet poor plasma by Coagulation assay

364

1.40

1.52

1.2

1.1

95.9

87.7

—

(3002222) Hepatitis E virus IgM Ab [Presence] in Serum

104

824

1.26

1.52

1.1

—

(3051596) Benzodiazepines [Presence] in Serum or Plasma by Screen method

3.33

1.52

1.0

1.1

—

(3016543) Leukocytes [#/volume] in Cerebral spinal fluid

334

2939

1.14

1.51

1.2

1.3

e6/l

30.0

29.7

0.01

269

2266

(3038071) Oxygen [Partial pressure] in Mixed venous blood

117

1.71

1.43

22.4

8.6

—

(3027475) Erythrocytes [#/volume] in Cerebral spinal fluid

333

2943

1.13

1.43

1.3

1.4

e6/l

501.4

2615.8

0.99

288

2380

(1175556) inFLIXimab Ab [Units/volume] in Serum by Immunoassay

532

1.31

1.42

2.3

2.4

au/ml

169.7

148.5

0.15

(3005715) Vancomycin [Mass/volume] in Serum or Plasma

108

868

1.24

1.42

6.2

6.4

mg/l

11.6

11.3

0.28

102

808

(3017509) Phencyclidine [Presence] in Urine

212

1.51

1.41

2.1

1.7

—

(3005322) IgE [Units/volume] in Serum or Plasma

1116

10454

1.07

1.39

1.3

u/ml

160.2

186.6

0.58

1036

9693

(3016913) Creatine kinase.MM [Enzymatic activity/volume] in Serum or Plasma by Electrophoresis

2.24

1.39

1.2

1.1

u/l

280.8

267.2

—

(3025378) Microscopic observation [Identifier] in Cervix by Cyto stain

440

1.34

1.37

1.1

—

(3016921) Smith extractable nuclear Ab [Units/volume] in Serum

448

4041

1.11

1.36

1.3

u/ml

10.1

6.8

0.26

443

(3028369) Herpes simplex virus 1+2 DNA [Presence] in Specimen by NAA with probe detection

177

1500

1.18

1.36

1.1

—

(3002348) Coagulation factor XII activity actual/normal in Platelet poor plasma by Coagulation assay

364

1.37

1.36

1.1

66.4

73.6

—

(3014702) Chromogranin A [Moles/volume] in Serum or Plasma

133

1099

1.21

1.35

3.3

2.9

nmol/l

5.3

9.1

0.32

128

1050

(3020044) Glucose [Moles/volume] in Cerebral spinal fluid

331

2938

1.13

1.34

1.2

mmol/l

3.7

3.6

1.08

308

2755

(3046861) Legionella sp Ag [Presence] in Urine

0.00

1.34

0.0

1.0

—

(40760847) Basement membrane Ab [Titer] in Serum by Immunofluorescence

495

1.31

1.32

1.2

1.3

—

603.8

—

(43055361) Metamyelocytes/Leukocytes [Pure number fraction] in Blood by Manual count

358

1.37

1.31

2.5

3.0

—

(3012202) Varicella zoster virus DNA [Presence] in Specimen by NAA with probe detection

505

1.30

1.2

—

(3022907) Direct antiglobulin test.polyspecific reagent [Presence] on Red Blood Cells

168

1.54

1.29

1.2

1.1

—

(3042975) Streptococcus sp identified in Isolate by Organism specific culture

159

1343

1.18

1.29

1.2

1.1

—

(3023709) Somatotropin [Mass/volume] in Serum or Plasma

480

1.31

1.28

1.7

2.2

ug/l

1.1

1.3

0.63

457

(3012447) Hantavirus puumala IgG Ab [Titer] in Serum

125

1033

1.21

1.28

1.1

—

(44786774) Adalimumab [Mass/volume] in Serum or Plasma

550

1.29

1.28

2.0

1.8

mg/l

8.5

9.4

0.82

442

(3014218) Bicarbonate [Moles/volume] standard in Arterial blood

417

3762

1.11

1.28

10.8

8.9

mmol/l

23.9

24.2

1.11

387

3552

(3011363) Streptococcus pneumoniae Ag [Presence] in Urine

621

1.27

1.28

1.1

—

(3035457) Cefaclor IgE Ab [Units/volume] in Serum

161

1.55

1.27

1.0

—

(3001467) Alkaline phosphatase.bone [Enzymatic activity/volume] in Serum or Plasma

148

1245

1.19

1.26

1.3

1.2

u/l

54.5

57.9

0.37

851

(3042299) inFLIXimab [Mass/volume] in Serum or Plasma

578

1.28

1.26

2.9

mg/l

7.0

8.3

1.10

450

(3024950) Chlamydia trachomatis DNA [Presence] in Urine by NAA with probe detection

3075

29686

1.04

1.25

2.1

—

(3034426) Prothrombin time (PT)

491

1.30

1.25

1.3

1.2

—

(3010156) C reactive protein [Mass/volume] in Serum or Plasma by High sensitivity method

630

6795

0.92

1.25

1.6

mg/l

3.6

3.4

0.43

454

4628

(3004716) Salmonella sp identified in Stool by Organism specific culture

859

9155

0.93

1.24

1.5

—

(42868497) Enterovirus IgM Ab [Presence] in Cerebral spinal fluid by Immunoassay

1.85

1.22

1.2

1.1

—

(40758895) Direct antiglobulin test.complement C3d specific reagent [Presence] on Red Blood Cells

329

1.37

1.21

1.5

1.4

—

(40758897) Direct antiglobulin test.IgG specific reagent [Presence] on Red Blood Cells

329

1.37

1.21

1.5

1.4

—

(3010375) cycloSPORINE [Mass/volume] in Blood

416

1.32

1.20

19.1

26.7

ug/l

115.0

113.8

0.04

342

(3006922) Hepatitis E virus Ab [Presence] in Serum

110

906

1.21

1.19

1.1

—

(3053028) Streptococcus sp identified in Specimen by Organism specific culture

127

1061

1.20

1.19

1.4

—

(3006999) Ribonucleoprotein extractable nuclear Ab [Units/volume] in Serum

452

4115

1.10

1.18

1.3

u/ml

8.7

9.4

0.08

681

(21494434) Karyotype in Bone marrow

550

1.27

1.16

1.2

—

(21494815) CD4 cells/100 lymphocytes in Specimen

1001

0.81

1.16

2.1

49.9

45.5

0.63

163

(42870308) Desmosome IgG Ab [Titer] in Serum by Immunofluorescence

480

1.29

1.15

1.2

1.3

titre

72.5

55.6

—

(3036603) Volume of Urine

720

1.23

1.15

2.0

1.6

2235.0

1954.8

0.78

128

(3016426) Methylmalonate [Moles/volume] in Serum or Plasma

0.00

1.15

0.0

1.1

—

253.5

—

(3030692) Respiratory virus DNA+RNA [Identifier] in Specimen by NAA with probe detection

131

1102

1.19

1.14

1.5

—

(3008295) Osmolality of Serum or Plasma

111

921

1.20

1.13

1.8

1.6

mosm/kgh2o

280.7

281.0

0.05

719

(37020445) Astrovirus RNA [Presence] in Stool by NAA with probe detection

377

1.32

1.13

1.2

1.3

—

(37021247) Adenovirus 40+41 DNA [Presence] in Stool by NAA with probe detection

377

1.32

1.13

1.2

1.3

—

(3009542) Hematocrit [Volume Fraction] of Blood

12188

122413

0.96

1.12

12.6

11.3

39.3

39.5

2.19

9325

99193

(36031861) Influenza virus A and B and SARS-CoV-2 (COVID-19) and Respiratory syncytial virus RNA panel - Respiratory system specimen by NAA with probe detection

499

4580

1.09

1.11

1.5

—

(3000012) Reticulocyte production index

413

1.31

1.11

1.5

1.4

—

(3006571) Polymorphonuclear cells/100 leukocytes in Synovial fluid

140

1190

1.17

1.10

1.7

1.6

49.2

48.6

0.06

738

(40763634) TCRG gene rearrangements [Presence] in Bone marrow by Molecular genetics method

136

0.51

1.09

1.3

1.1

—

(3016251) Hemoglobin.gastrointestinal [Presence] in Stool

554

5113

1.08

1.09

2.3

—

(3042517) Benzodiazepines panel - Urine

235

1.40

1.06

2.1

2.7

—

(40768441) Liver Pathology biopsy report

106

883

1.20

1.05

1.4

1.3

—

(3025315) Body weight

1.75

1.05

4.7

4.1

—

(44806118)

127

1076

1.18

1.05

1.4

—

(44790049)

127

1076

1.18

1.05

1.4

—

(44790047)

127

1077

1.18

1.04

1.4

—

(44790048)

127

1077

1.18

1.04

1.4

—

(3020191) Ethanol [Moles/volume] in Serum or Plasma

803

1.21

1.03

1.9

1.5

promille

1.0

1.3

1.60

611

(40758292) HTLV I+II Ab panel - Serum

178

0.56

1.03

1.2

1.3

—

(3014114) Aureobasidium pullulans IgG Ab [Mass/volume] in Serum

2.27

1.03

1.2

1.0

—

(3023601) Vancomycin resistant enterococcus [Presence] in Specimen by Organism specific culture

731

1.22

1.03

3.0

2.7

—

(3006418) Campylobacter sp identified in Tissue by Organism specific culture

378

4124

0.91

1.02

1.2

1.1

—

(42529201) Cancer Ag 19-9 [Units/volume] in Serum or Plasma by Immunoassay

179

1562

1.14

1.01

2.8

3.3

u/ml

137.7

635.4

1.57

161

1416

(1761868) Lipid panel - Serum or Plasma

5167

50525

1.03

1.01

2.5

2.3

—

(4015189)

179

1.45

1.01

2.0

2.3

—

(42868691) Thyroxine (T4) free [Moles/volume] in Serum or Plasma by Dialysis

553

1.25

1.00

1.5

1.4

pmol/l

13.8

13.7

0.05

472

(43055089) Myosin Ab [Presence] in Serum or Plasma by Immunoblot

553

1.25

1.00

1.1

—

(3052649) Adenosine deaminase [Enzymatic activity/volume] in Serum or Plasma

448

0.73

1.00

1.3

1.4

u/l

11.8

11.4

0.21

432

(40768793) Breast Pathology biopsy report

390

4241

0.91

0.99

1.3

—

(3044290) Cell count panel - Cerebral spinal fluid

307

2773

1.11

0.99

1.2

1.3

—

(3013676) Sertraline [Moles/volume] in Serum or Plasma

0.00

0.97

0.0

1.3

—

213.2

—

(3000570) Elastase.pancreatic [Mass/mass] in Stool

338

3071

1.10

0.97

1.4

1.3

ug/g

306.0

302.6

0.10

187

1609

(1617658) Protocol used for examination of sentinel lymph nodes

113

1324

0.85

0.97

1.0

—

(3038769) Chlamydophila pneumoniae IgG Ab [Units/volume] in Serum by Immunoassay

441

1.27

0.95

1.1

u/ml

57.2

55.6

0.05

432

(40768806) Pleura Pathology biopsy report

501

0.76

0.95

2.0

1.4

—

(3024263) Appearance of Synovial fluid

450

1.26

0.95

2.1

1.9

—

(3011831) Apolipoprotein B/Apolipoprotein A-I [Percentile]

733

0.80

0.93

1.2

—

(3011288) Drugs identified in Urine by Screen method

574

5346

1.07

0.93

4.7

2.6

—

(36304052) Adalimumab Ab [Units/volume] in Serum or Plasma

434

1.26

0.93

1.9

1.6

au/ml

70.3

143.7

—

(3048469) 10-Hydroxycarbazepine [Moles/volume] in Serum or Plasma

461

1.26

0.92

2.9

2.4

umol/l

48.1

51.1

0.41

386

(3013527) Hepatitis B virus core IgM Ab [Presence] in Serum

330

3600

0.91

0.92

1.2

1.3

—

(3015076) Soybean IgE Ab [Units/volume] in Serum

1111

0.84

0.91

1.1

1.0

u/ml

0.1

0.3

4.71

144

(3011951) Aspergillus fumigatus IgE Ab [Units/volume] in Serum

133

1148

1.16

0.90

1.3

1.2

u/ml

0.4

0.8

0.84

441

(3016845) Adenovirus Ag [Presence] in Specimen by Immunofluorescence

552

0.78

0.90

1.0

1.2

—

(3022914) Cancer Ag 19-9 [Units/volume] in Serum or Plasma

263

2896

0.90

0.89

3.3

3.4

u/ml

484.5

417.8

0.09

223

2457

(3033888) Pepsinogen I [Mass/volume] in Serum or Plasma

287

1.32

0.89

1.0

ug/l

65.1

76.2

1.41

252

(3035285) Chloride [Moles/volume] in Venous blood

735

1.20

0.89

2.7

1.9

mmol/l

105.1

105.9

0.90

730

(3029612) Listeria sp Ab [Titer] in Serum

1.74

0.89

1.4

—

(3026389) Candida sp identified in Specimen by Organism specific culture

249

2241

1.11

0.89

1.4

1.3

—

(3045716) Anion gap in Serum or Plasma

340

1.29

0.88

3.7

2.5

mmol/l

9.0

9.3

0.26

251

(3019473) Protein [Mass/volume] in Cerebral spinal fluid

364

3338

1.09

0.88

1.2

1.3

mg/l

436.2

462.2

0.43

351

3185

(3043257) Herpes virus 6 IgG Ab [Presence] in Cerebral spinal fluid

1.69

0.88

1.2

1.0

—

(43055222) Platelet function.collagen + Adenosine diphosphate induced and EPINEPHrine induced panel - Blood

219

1.37

0.87

1.4

1.3

—

(3020485) Acetaminophen [Moles/volume] in Serum or Plasma

537

1.23

0.87

1.9

2.3

umol/l

208.6

148.3

0.39

269

(3003740) Influenza virus B Ag [Presence] in Specimen

269

2952

0.91

0.86

1.1

—

(3023659) Complement C1 esterase inhibitor.functional/Complement C1 esterase inhibitor.total in Serum or Plasma

601

1.21

0.86

1.1

1.2

113.4

110.9

0.34

535

(3022192) Triglyceride [Mass/volume] in Serum or Plasma

368

1.27

0.86

1.8

2.1

—

(44806071)

220

1.36

0.86

1.1

—

(3014765) Yersinia sp identified in Stool by Organism specific culture

386

4165

0.92

0.85

1.2

1.1

—

(42529406) Shigella sp [Presence] in Stool by Culture

387

4174

0.92

0.85

1.2

—

(37020957) Sapovirus genogroups I+II+IV+V RNA [Presence] in Stool by NAA with probe detection

476

1.24

0.85

1.2

1.3

—

(3035320) C reactive protein [Mass/volume] in Body fluid

107

915

1.17

0.84

2.6

2.2

—

(42868499) Enterovirus IgG Ab [Presence] in Cerebral spinal fluid by Immunoassay

120

1.50

0.84

1.1

—

(3047826) Mullerian inhibiting substance [Mass/volume] in Serum or Plasma

453

4853

0.93

0.84

1.4

1.3

ug/l

3.2

3.3

0.20

398

4442

(3000213) Normetanephrine [Moles/time] in 24 hour Urine

112

1.51

0.83

1.1

umol/24h

1.5

0.08

112

(42869457) Rotavirus RNA [Identifier] in Stool by NAA with probe detection

486

1.23

0.83

1.2

1.3

—

(3000285) Sodium [Moles/volume] in Blood

1.59

0.83

1.0

1.1

—

(3051387) C reactive protein [Mass/volume] in Capillary blood

251

2271

1.10

0.83

3.8

3.2

mg/l

20.8

23.4

0.63

162

1349

(3000093) Morphology [Interpretation] in Blood Narrative

769

1.18

0.82

1.2

1.1

—

(3010144) Erythrocytes [#/volume] in Synovial fluid

825

1.17

0.82

1.3

1.5

e6/l

29553.6

48479.0

0.33

561

(3043138) Epithelial cells.renal [#/area] in Urine by Computer assisted method

1.87

0.81

1.3

1.0

u/field

0.8

1.0

—

(3002523) Influenza virus A Ag [Presence] in Specimen

270

2951

0.91

0.81

1.1

—

(3011325) HIV 1+2 Ab [Presence] in Serum

1.64

0.80

1.0

1.1

—

(3033942) Copper [Moles/time] in 24 hour Urine

1.64

0.80

1.5

1.2

umol/24h

2.2

0.7

—

(3027135) IgG subclass 1 [Mass/volume] in Serum

157

1386

1.13

0.80

1.4

g/l

6.7

6.6

0.24

109

980

(42870298) TPMT gene c.238G>C+460G>A+719A>G [Identifier] in Blood or Tissue by Molecular genetics method Narrative

164

0.61

0.80

1.1

1.0

—

(3028371) Actinomyces sp identified in Specimen by Organism specific culture

1.60

0.80

1.1

1.2

—

(4133840)

293

1.29

0.79

1.3

1.1

—

(40759812) SCL-70 extractable nuclear Ab [Presence] in Serum by Immunoblot

143

1256

1.14

0.79

1.2

—

(3011391) Calcitriol [Moles/volume] in Serum or Plasma

128

1116

1.15

0.79

1.1

1.2

—

(3041354) Potassium [Moles/volume] in Venous blood

736

1.18

0.79

2.7

1.9

mmol/l

4.0

3.9

0.36

731

(21494227) Amikacin free [Mass/volume] in Serum or Plasma

0.00

0.79

0.0

5.3

—

6.0

—

(40761545) Erythrocytes.dysmorphic [Presence] in Urine sediment by Light microscopy

1.72

0.79

1.3

1.1

—

(3005702) Mycobacterium sp identified in Specimen by Organism specific culture

133

1508

0.88

0.78

1.5

1.4

—

(40759849) Smith extractable nuclear Ab [Presence] in Serum by Immunoblot

143

1258

1.13

0.78

1.2

—

(40765096) Chromosome analysis panel by Banding

190

1.37

0.77

1.2

1.1

—

(3009991) Angiotensin converting enzyme [Enzymatic activity/volume] in Cerebral spinal fluid

114

988

1.15

0.77

1.0

1.1

u/l

1.0

0.50

409

(44816752) ERBB2 gene copy number/nucleus in Tissue by FISH

768

0.83

0.77

1.1

—

(3010521) Mycoplasma pneumoniae IgM Ab [Presence] in Serum by Immunoassay

459

4280

1.07

0.76

1.2

—

(44813793)

139

1224

1.13

0.75

1.1

—

(40759843) Sjogrens syndrome-A extractable nuclear Ab [Presence] in Serum by Immunoblot

144

1271

1.13

0.75

1.2

—

(40759842) Ribonucleoprotein extractable nuclear Ab [Presence] in Serum by Immunoblot

144

1271

1.13

0.75

1.2

—

(3028192) IgG subclass 2 [Mass/volume] in Serum

156

1384

1.13

0.75

1.4

g/l

3.1

3.0

0.50

108

980

(3024139) IgG subclass 3 [Mass/volume] in Serum

156

1385

1.12

0.74

1.4

g/l

0.4

0.32

110

984

(3049804) Myeloperoxidase IgG Ab [Units/volume] in Serum

297

2727

1.09

0.74

1.3

1.5

iu/ml

31.0

15.7

—

(3034368) Herpes virus 6 IgM Ab [Presence] in Cerebral spinal fluid

1.60

0.74

1.2

1.0

—

(40759836) Histone Ab [Presence] in Serum by Immunoblot

142

1255

1.13

0.73

1.2

—

(3003245) Complement C1 esterase inhibitor [Mass/volume] in Serum or Plasma

650

1.18

0.73

1.2

g/l

0.3

0.67

524

(40759844) Sjogrens syndrome-B extractable nuclear Ab [Presence] in Serum by Immunoblot

144

1274

1.13

0.73

1.2

—

(3020951) Lymphocytes/100 leukocytes in Cerebral spinal fluid

141

1.42

0.73

1.1

1.5

52.8

55.4

—

(3001820) Epstein Barr virus nuclear Ab [Presence] in Serum

1.84

0.73

1.0

1.1

—

(3021387) Prolactin [Units/volume] in Serum or Plasma

920

8773

1.05

0.73

1.5

1.6

mu/l

286.8

318.7

1.89

797

7803

(3031659) Enterovirus NOS Ab [Titer] in Cerebral spinal fluid

1.99

0.72

1.2

1.1

—

(3016914) Bacteria identified in Cerebral spinal fluid by Culture

125

1097

1.14

0.72

1.3

1.5

—

(44816893) Food Allergen Mix 50 (Kiwi+Pineapple+Banana+Mango) IgE Ab [Units/volume] in Serum by Multidisk

615

1.18

0.71

1.0

—

(3024980) IgG subclass 4 [Mass/volume] in Serum

230

2094

1.10

0.70

1.4

1.5

g/l

0.6

0.24

176

1586

(3032390) JC virus DNA [#/volume] (viral load) in Urine by NAA with probe detection

1.92

0.70

1.0

1.4

—

(3014271) Vancomycin [Susceptibility]

220

1.32

0.70

2.3

2.8

—

(42868647) JC virus Ab [Presence] in Serum or Plasma by Immunoassay

331

0.75

0.70

1.5

2.7

—

(3014891) Appearance of Pleural fluid

1.55

0.69

1.3

2.1

—

(3013139) Helicobacter pylori Ag [Presence] in Stool

946

9843

0.96

0.69

1.2

—

(3023323) Follitropin [Units/volume] in Serum or Plasma

1466

14139

1.04

0.69

1.3

iu/l

26.3

26.9

0.30

1308

12323

(3014326) Insulin-like growth factor-I [Moles/volume] in Serum or Plasma

124

1092

1.13

0.69

1.8

1.9

nmol/l

19.0

19.6

0.36

119

1044

(3000475) Leukocytes [#/volume] in Synovial fluid

239

2184

1.09

0.68

1.7

e6/l

12816.2

8298.5

0.86

183

1598

(1001926) Buprenorphine [Presence] in Urine by Screen method

619

5855

1.06

0.68

3.1

2.0

—

(3033705) Calcium.ionized [Moles/volume] in Venous blood

720

1.16

0.68

2.8

2.0

—

(3003752) BK virus DNA [Units/volume] (viral load) in Urine by NAA with probe detection

1.85

0.68

1.0

1.4

—

(3009461) 5-Hydroxyindoleacetate [Moles/time] in 24 hour Urine

1.66

0.68

1.3

1.2

—

(3004269) Kappa light chains [Mass/time] in 24 hour Urine

1.53

0.68

1.5

3.2

—

(3051611) Lipemic interference index of Serum or Plasma

110

963

1.14

0.67

2.8

2.9

—

(3027300) Silver Birch IgE Ab [Units/volume] in Serum

647

0.83

0.66

1.1

1.0

u/ml

7.0

8.7

—

(40758310) Human epididymis protein 4 [Moles/volume] in Serum or Plasma

488

5160

0.94

0.66

1.4

pmol/l

81.5

102.9

1.83

482

5025

(3006257) Acetylcholine receptor Ab [Moles/volume] in Serum

787

1.15

0.66

1.1

nmol/l

0.2

6.2

1.61

146

(3029879) Epithelial cells.squamous [#/volume] in Urine by Automated count

1628

15747

1.03

0.66

2.8

2.5

e6/l

5.7

4.9

1.24

895

7948

(3023091) Interleukin 6 [Mass/volume] in Serum or Plasma

153

1.37

0.66

1.1

1.5

ng/l

92.0

49.7

—

(3047007) Chlamydophila sp Ab [Presence] in Serum

268

2467

1.08

0.66

1.2

—

(3025443) Phadiatop IgE Ab [Units/volume] in Serum

826

1.15

0.65

1.1

u/ml

9.8

11.3

0.11

138

(4094501)

272

2507

1.08

0.65

1.1

—

(3029338) Protein.monoclonal band 3 [Mass/volume] in Serum or Plasma by Electrophoresis

217

1981

1.09

0.64

1.9

2.0

g/l

0.0

0.66

201

1807

(3008364) Apolipoprotein A-I [Mass/volume] in Serum or Plasma

913

0.86

0.64

1.3

1.2

g/l

1.5

—

(3042631) Mycobacterium sp identified in Specimen

104

911

1.14

0.64

2.2

2.6

—

(3009466) Valproate [Moles/volume] in Serum or Plasma

142

1577

0.90

0.63

4.4

5.5

umol/l

363.6

379.5

0.68

120

1368

(3043410) Blood group antigens tested for on Red Blood Cells

322

1.24

0.63

1.3

1.5

—

(3003031) Transferrin.carbohydrate deficient.disialo/Transferrin.total in Serum or Plasma

1601

16448

0.97

0.63

1.8

1.6

1.4

1.3

3.80

1421

14815

(3012215) Mononuclear cells/100 leukocytes in Synovial fluid

233

1.28

0.63

1.5

1.3

45.1

45.7

0.03

148

(40757349) CD3+CD4+ (T4 helper) cells/CD3+CD8+ (T8 suppressor cells) cells [# Ratio] in Blood

380

0.79

0.62

3.1

—

(3017895) Helicobacter pylori Ab [Units/volume] in Serum

606

5748

1.05

0.62

1.6

1.7

—

(40765161) Human bocavirus DNA [Presence] in Specimen by NAA with probe detection

158

1424

1.11

0.62

1.6

—

(3016273) Islet cell 512 Ab [Units/volume] in Serum

1.52

0.62

1.0

—

(3006270) Folate [Moles/volume] in Blood

103

905

1.14

0.61

1.2

1.1

nmol/l

392.2

404.2

0.26

839

(3042391) t(9;22)(q34.1;q11)(ABL1,BCR) e1a2 fusion transcript/control transcript [# Ratio] in Blood or Tissue by Molecular genetics method

1.58

0.61

5.0

4.1

—

(3020874) Milk IgE Ab [Units/volume] in Serum

134

1198

1.12

0.61

1.1

1.0

u/ml

0.3

1.2

1.62

310

(3037551) Cancer Ag 125 [Units/volume] in Serum or Plasma

1061

10973

0.96

0.61

2.7

2.9

u/ml

35.1

40.7

0.48

1031

10614

(3029075) Extractable nuclear Ab panel - Serum

442

1.20

0.61

1.1

—

(3014051) Protein [Presence] in Urine by Test strip

302

2805

1.08

0.61

2.0

1.9

—

(3045788) Cell count panel - Pleural fluid

433

0.81

0.60

1.8

1.5

—

(3001218) Citrate [Mass/time] in 24 hour Urine

0.00

0.60

0.0

1.4

—

(3039162) Centromere protein B Ab [Units/volume] in Serum

221

2028

1.09

0.60

1.3

u/ml

36.2

53.8

0.52

144

(37020300) Entamoeba histolytica DNA [Presence] in Stool by NAA with probe detection

619

1.16

0.59

1.1

1.2

—

(4062490)

154

1391

1.11

0.59

1.4

—

(42868766) Dientamoeba fragilis DNA [Presence] in Stool by NAA with probe detection

499

1.18

0.59

1.1

1.3

—

(3045066) Thymidine kinase [Enzymatic activity/volume] in Serum

242

0.74

0.58

1.9

1.5

u/l

9.6

41.3

2.10

207

(3028167) CD3+CD4+ (T4 helper) cells [#/volume] in Blood

808

0.86

0.58

2.6

e6/l

797.1

855.8

0.30

370

(3020013) Alkaline phosphatase.intestinal [Enzymatic activity/volume] in Serum or Plasma

741

1.14

0.58

1.6

u/l

9.8

5.4

0.96

356

(1175553) Vedolizumab and Vedolizumab Ab panel [Mass/volume] - Serum or Plasma

131

1.37

0.58

2.1

2.2

—

(3003157) Bacteria [#/volume] in Mother's milk

1.56

0.58

6.5

6.8

—

(44816808) CXCL13 Ag [Mass/volume] in Cerebral spinal fluid

454

1.19

0.58

1.0

1.1

ng/l

323.8

446.7

—

(40757373) Influenza virus identified in Isolate

166

1.32

0.57

1.8

1.5

—

(3042111) Morphology [Interpretation] in Bone marrow Narrative

122

1090

1.12

0.57

1.7

1.6

—

(37020271) Myelin oligodendrocyte glycoprotein Ab [Titer] in Serum by Cell binding immunofluorescent assay

207

0.72

0.57

1.1

—

(3042552) Rheumatoid factor [Units/volume] in Pleural fluid

1.48

0.57

1.0

—

5.0

—

(46237023) Hepatitis B virus core and surface Ab and surface Ag panel - Serum

500

5249

0.95

0.56

1.5

1.4

—

(3027544) Mycobacterium sp identified in Sputum by Organism specific culture

645

0.85

0.56

3.3

4.0

—

(1175715) Chlamydophila pneumoniae IgM Ab [Presence] in Serum by Immunoassay

260

2411

1.08

0.56

1.1

—

(3028433) Virus identified in Specimen by Culture

355

1.21

0.56

1.0

1.1

—

(3032743) Legionella sp IgG Ab [Presence] in Serum

1.45

0.56

1.1

—

(3021879) Hepatitis B virus core Ab [Presence] in Serum

1302

12594

1.03

0.55

1.5

—

(3051593) INR in Capillary blood by Coagulation assay

229

1.26

0.55

5.1

6.3

—

(3032699) Streptococcus pneumoniae DNA [Presence] in Specimen by NAA with probe detection

438

1.18

0.55

1.4

—

(3032868) Hemoglobin electrophoresis panel in Blood

124

0.64

0.54

1.5

1.6

—

(3015183) Erythrocyte sedimentation rate

105

934

1.12

0.54

1.2

—

(3043362) Influenza virus B Ag [Presence] in Nasopharynx by Immunoassay

202

1858

1.09

0.54

1.2

—

(3046524) Influenza virus A Ag [Presence] in Nasopharynx by Immunoassay

202

1859

1.08

0.53

1.2

—

(46235760) Methicillin resistant Staphylococcus aureus [Presence] in Pharynx by Organism specific culture

1.46

0.53

2.0

—

(3018559) Microscopic observation [Identifier] in Buccal smear by Cyto stain

896

0.88

0.53

1.1

—

(3037875) Bordetella parapertussis DNA [Presence] in Specimen by NAA with probe detection

413

1.18

0.52

1.4

—

(3028286) Albumin [Mass/volume] in Serum or Plasma by Electrophoresis

234

2170

1.08

0.52

1.8

2.0

g/l

38.5

38.8

0.37

210

1909

(3045209) Lutropin/Follitropin [Ratio] in Serum or Plasma

489

0.84

0.52

1.2

—

(723473) SARS-CoV-2 (COVID-19) IgA Ab [Presence] in Serum or Plasma by Immunoassay

0.62

0.52

1.0

—

(3008757) Leukocyte morphology finding [Identifier] in Blood

102

910

1.12

0.51

2.6

3.0

—

(3036432) Mycobacterium tuberculosis genotype [Identifier] in Isolate

296

1.21

0.50

3.6

4.4

—

(3000919) Neutrophils/100 leukocytes in Pleural fluid

109

1.37

0.50

2.1

1.3

38.5

24.2

0.88

(3035947) Staphylolysin Ab [Units/volume] in Serum

471

1.17

0.50

1.0

1.1

iu/ml

4.4

3.3

—

(3018001) Oat IgE Ab [Units/volume] in Serum

144

1.32

0.49

1.1

1.0

u/ml

1.4

—

(3002331) Protein [Mass/volume] in Peritoneal fluid

144

1.32

0.49

1.5

1.4

g/l

27.6

0.00

110

(3025577) Chromium [Mass/volume] in Blood

297

1.21

0.49

2.1

ug/l

2.4

2.9

0.41

259

(36305771) Cryptosporidium sp DNA [Presence] in Stool by NAA with probe detection

123

1113

1.10

0.48

1.1

1.2

—

(3018993) Complement total hemolytic CH100 [Units/volume] in Serum or Plasma

420

0.83

0.48

1.7

1.2

—

(3035999) Lactate [Moles/volume] in Cerebral spinal fluid

114

1028

1.11

0.48

1.3

mmol/l

2.1

1.9

0.65

109

957

(3021788) Differential panel - Synovial fluid

188

1736

1.08

0.48

1.6

—

(3028531) Enolase.neuron specific [Mass/volume] in Serum or Plasma

613

1.14

0.48

1.7

2.1

ug/l

52.2

22.4

0.41

603

(3025130) Human papilloma virus identified in Specimen

382

4014

0.95

0.47

1.7

—

(3005665) Streptococcus pneumoniae Danish serotype 6B IgG Ab [Mass/volume] in Serum

154

0.71

0.47

1.9

1.6

mg/l

1.1

2.4

—

(36204094) Streptococcus pneumoniae Danish serotype 23F IgG Ab [Mass/volume] in Serum

154

0.71

0.47

1.9

1.6

mg/l

0.5

2.8

—

101

(37020937) Giardia lamblia DNA [Presence] in Stool by NAA with probe detection

122

1107

1.10

0.46

1.1

1.2

—

(3034552) Adenosine deaminase [Enzymatic activity/volume] in Cerebral spinal fluid

0.61

0.45

1.2

1.0

—

3.9

—

(3029379) Protein.monoclonal band 4 [Mass/volume] in Serum or Plasma by Electrophoresis

211

1963

1.07

0.45

1.9

2.0

g/l

0.0

0.00

199

1804

(3008733) Herpes simplex virus DNA [Presence] in Cerebral spinal fluid by NAA with probe detection

663

1.13

0.45

1.2

1.1

—

(3032057) Clostridioides difficile [Presence] in Stool

191

1.25

0.45

2.0

1.8

—

(3045142) Bone marrow Pathology biopsy report

786

1.12

0.45

1.4

1.3

—

(3016018) Differential panel - Cerebral spinal fluid

157

1445

1.08

0.44

1.3

1.4

—

(40764127) Haemophilus influenzae DNA [Presence] in Specimen by NAA with probe detection

402

1.17

0.44

1.4

—

(3038546) Human coronavirus OC43 RNA [Presence] in Specimen by NAA with probe detection

759

1.12

0.44

1.3

1.6

—

(3040359) Human coronavirus NL63 RNA [Presence] in Specimen by NAA with probe detection

759

1.12

0.44

1.3

1.6

—

(3041642) Human coronavirus 229E RNA [Presence] in Specimen by NAA with probe detection

759

1.12

0.44

1.3

1.6

—

(3025271) CD3-CD16+CD56+ (Natural killer) cells [#/volume] in Blood

903

0.89

0.44

2.5

e9/l

0.2

0.65

762

(3046426) Aquaporin 4 water channel IgG Ab [Presence] in Serum or Plasma

372

0.83

0.44

1.1

—

(42529582) MDA5 Ab [Presence] in Serum by Line blot

292

1.20

0.44

1.1

—

(3013637) Mi-2 Ab [Presence] in Serum

292

1.20

0.44

1.1

—

(42528593) TIF1-gamma Ab [Presence] in Serum by Line blot

292

1.20

0.44

1.1

—

(42529598) SUMO-activating enzyme subunit 1 Ab [Presence] in Serum by Line blot

292

1.20

0.44

1.1

—

(3027545) Mycoplasma pneumoniae Ab [Presence] in Serum by Immunoassay

498

4760

1.04

0.43

1.4

—

(3014162) Mycobacterium tuberculosis DNA [Presence] in Specimen by NAA with probe detection

238

2230

1.07

0.43

2.6

—

(3046904) Somatotropin [Units/volume] in Serum or Plasma

1.61

0.43

1.0

2.3

mu/l

3.3

2.0

—

(3009306) Alpha-1-Fetoprotein [Mass/volume] in Serum or Plasma

157

1.27

0.42

1.6

2.0

—

(3016879) Cocaine [Presence] in Urine

721

6952

1.04

0.41

2.9

1.9

—

(21494567) Legionella sp IgM Ab [Presence] in Serum

1.38

0.41

1.1

—

(42868555) Amyloid beta 40 peptide [Mass/volume] in Cerebral spinal fluid

0.00

0.41

0.0

1.0

—

10946.0

—

(3011544) Albumin [Mass/volume] in Pleural fluid

1.51

0.41

1.2

1.1

g/l

19.2

19.3

—

(3026725) Estradiol (E2) [Moles/volume] in Serum or Plasma

455

4347

1.05

0.41

1.5

1.4

nmol/l

0.5

0.14

366

3463

(3025018) Bordetella pertussis Ab [Titer] in Serum

111

1011

1.10

0.41

1.1

1.2

—

(3014178) Parietal cell Ab [Units/volume] in Serum

0.00

0.41

0.0

1.1

—

(3026910) Gamma glutamyl transferase [Enzymatic activity/volume] in Serum or Plasma

9021

89429

1.02

0.41

3.0

2.8

u/l

38.7

34.7

5.49

8590

85277

(3010254) Herpes simplex virus identified in Specimen by Organism specific culture

360

1.16

0.40

1.2

1.1

—

(3017986) Aspergillus versicolor IgE Ab [Units/volume] in Serum

1.42

0.39

1.0

—

(3007302) Hemoglobin [Mass/volume] in Mixed venous blood

1.42

0.39

71.8

13.8

—

(3044242) Glucose [Moles/volume] in Arterial blood

324

1.17

0.39

1.9

—

(40769427) Triglyceride [Moles/volume] in Peritoneal fluid

0.00

0.39

0.0

1.6

—

1864.1

—

(3012138) Guinea pig epithelium IgE Ab [Units/volume] in Serum

0.00

0.39

0.0

1.0

—

2.4

—

(3012494) Peanut IgE Ab [Units/volume] in Serum

540

1.13

0.38

1.1

u/ml

0.2

2.3

3.36

304

(3043870) Heparin induced platelet Ab [Units/volume] in Serum

1.36

0.38

1.1

1.2

—

(3001729) Color of Synovial fluid

1.36

0.38

1.2

1.7

—

(42868421) Varicella zoster virus IgM Ab [Presence] in Cerebral spinal fluid by Immunoassay

297

1.18

0.38

1.1

—

(40767665) Peanut recombinant (rAra h) 9 IgE Ab [Units/volume] in Serum

178

1.23

0.38

1.0

u/ml

0.1

0.4

0.95

(3008536) Aspergillus sp Ab [Presence] in Serum

158

0.76

0.37

1.1

2.1

—

(36032419) SARS-CoV-2 (COVID-19) Ag [Presence] in Upper respiratory specimen by Immunoassay

610

5880

1.04

0.37

2.3

2.1

—

(3016894) Varicella zoster virus DNA [Presence] in Cerebral spinal fluid by NAA with probe detection

685

1.11

0.36

1.2

1.1

—

(3023365) Varicella zoster virus Ab [Titer] in Cerebral spinal fluid

143

1.26

0.36

1.1

—

(1002183) Plasma cells monotypic population [Identifier] in Bone marrow by Flow cytometry (FC)

0.64

0.35

1.6

1.3

—

(40760871) Heparin induced platelet Ab [Presence] in Serum or Plasma by Immunoassay

1.42

0.35

1.0

1.1

—

(3046299) Protein.monoclonal [Mass/volume] in Serum or Plasma by Electrophoresis

1.42

0.35

1.7

7.3

—

(40762365) Oxygen content in Arterial blood by calculation

1.33

0.35

1.8

ml/dl

15.6

14.8

0.68

(3023421) Hepatitis B virus surface Ab [Units/volume] in Serum

793

7690

1.03

0.35

1.3

miu/ml

204.8

231.8

1.42

370

3955

(4027681)

124

1147

1.08

0.34

1.4

1.2

—

(3002670) Multiple inhalant allergen IgE Ab [Units/volume] in Serum

917

0.91

0.34

1.8

1.6

—

(3040363) Hepatitis A virus IgG Ab [Presence] in Serum by Immunoassay

109

1004

1.08

0.34

1.1

—

(3045683) HLA typing for celiac disease panel - Blood or Tissue

110

1185

0.93

0.33

1.0

—

(36306090) Helicobacter pylori [Presence] in Tissue by Organism specific culture

466

0.88

0.33

1.1

—

(3016616) Dehydroepiandrosterone sulfate (DHEA-S) [Moles/volume] in Serum or Plasma

143

1333

1.07

0.33

1.3

umol/l

5.2

5.5

0.43

130

1236

(3045781) Inhibin B [Mass/volume] in Serum or Plasma

387

1.13

0.32

3.2

2.8

ng/l

67.2

90.7

0.67

174

(40767663) Brazil Nut recombinant (rBer e) 1 IgE Ab [Units/volume] in Serum

119

1.26

0.31

1.0

—

(3013566) Clostridioides difficile [Presence] in Stool by Organism specific culture

408

1.12

0.30

1.1

1.2

—

(40761847) Hazelnut recombinant (rCor a) 8 IgE Ab [Units/volume] in Serum

230

1.17

0.30

1.0

u/ml

0.0

0.1

1.05

128

(3032567) Hepatitis B virus DNA [Units/volume] (viral load) in Serum or Plasma by NAA with probe detection

286

1.15

0.30

1.2

1.7

—

500.2

—

(3026692) Albumin [Mass/volume] in Peritoneal fluid

166

1.20

0.29

1.3

1.4

g/l

16.1

13.4

0.82

129

(3042585) Pyridoxine [Moles/volume] in Serum or Plasma

287

1.15

0.29

1.3

nmol/l

146.5

108.7

0.47

223

(3017115) Methotrexate [Moles/volume] in Serum or Plasma

107

0.75

0.29

6.9

6.3

umol/l

0.5

0.4

—

(3035611) Eosinophils/100 leukocytes in Synovial fluid

1.22

0.28

1.3

1.8

0.3

0.2

—

(3005082) Progesterone [Moles/volume] in Serum or Plasma

210

1994

1.05

0.28

1.3

1.4

nmol/l

28.2

31.9

1.35

188

1833

(40768795) Lymph node Pathology biopsy report

117

1091

1.07

0.28

1.1

1.2

—

(37021073) Hepatitis C virus genotype in Serum or Plasma by Sequencing

162

0.80

0.28

1.3

1.2

—

(3012441) Differential panel - Pleural fluid

449

0.89

0.28

2.0

1.4

—

(42869547) Procollagen type III.N-terminal propeptide [Mass/volume] in Serum

363

1.13

0.28

1.6

1.7

ug/l

9.1

8.4

0.54

363

(3041678) Intrinsic coagulation system thromboelastography panel - Blood

1.27

0.27

1.1

1.3

—

(723474) SARS-CoV-2 (COVID-19) IgG Ab [Presence] in Serum or Plasma by Immunoassay

353

0.88

0.27

1.1

—

(3042596) Human coronavirus RNA [Presence] in Specimen by NAA with probe detection

910

1.07

0.27

1.6

1.5

—

(46234834) Bacteria identified in Bone by Anaerobe+Aerobe culture

1.25

0.27

1.1

—

(3043109) Cytology report of Tissue fine needle aspirate Cyto stain

340

3270

1.04

0.27

1.3

1.2

—

(3020073) CD3+CD4+ (T4 helper) cells/CD3+CD8+ (T8 suppressor cells) cells [# Ratio] in Specimen

346

1.12

0.26

1.9

2.0

—

(3005156) Respiratory syncytial virus A RNA [Presence] in Specimen by NAA with probe detection

373

0.88

0.26

1.5

1.9

—

(3000108) Respiratory syncytial virus B RNA [Presence] in Specimen by NAA with probe detection

373

0.88

0.26

1.5

1.9

—

(3023939) Sjogrens syndrome-A extractable nuclear Ab [Units/volume] in Serum

372

3587

1.04

0.26

1.2

1.3

u/ml

48.5

42.7

0.26

387

(4010399)

785

8005

0.98

0.26

1.4

—

(3030429) Borrelia sp DNA [Identifier] in Specimen by NAA with probe detection

435

0.89

0.26

1.1

—

(3011841) English Walnut IgE Ab [Units/volume] in Serum

187

1.17

0.26

1.0

u/ml

0.0

0.8

0.69

134

(3041918) Cholesterol [Moles/volume] in Pleural fluid

1.26

0.25

1.2

1.3

mmol/l

1.9

2.1

—

(42868415) European tick borne encephalitis virus IgM Ab [Presence] in Cerebral spinal fluid by Immunoassay

245

0.85

0.25

1.1

—

(3019977) pH of Arterial blood

403

0.89

0.25

1.6

2.7

7.4

1.28

111

(3023410) Appearance of Cerebral spinal fluid

135

1424

0.94

0.25

1.3

1.4

—

(3045156) Carbon dioxide [Partial pressure] adjusted to patient's actual temperature in Arterial blood

255

0.86

0.25

1.6

2.9

—

(3022803) Oxygen [Partial pressure] adjusted to patient's actual temperature in Arterial blood

255

0.86

0.25

1.6

2.9

—

(3018387) Mycoplasma pneumoniae IgG Ab [Units/volume] in Serum

278

2672

1.04

0.24

1.1

au/ml

13.2

10.9

0.14

195

(3023420) DNA double strand Ab [Units/volume] in Serum

182

1733

1.05

0.24

1.9

1.6

iu/ml

28.1

34.3

0.54

(43055514) Macroprolactin [Presence] in Serum or Plasma

640

0.92

0.24

1.4

—

(3000494) Fungus identified in Specimen by Culture

1345

13622

0.98

0.23

1.4

—

(3044212) Herpes simplex virus 1+2 IgM Ab [Presence] in Cerebral spinal fluid

302

1.12

0.23

1.1

—

(3034780) Angiotensin converting enzyme [Enzymatic activity/volume] in Serum or Plasma

544

5291

1.03

0.23

2.0

2.1

u/l

39.3

39.6

0.16

501

4884

(3008230) Borrelia burgdorferi IgM Ab [Units/volume] in Serum

984

9992

0.98

0.23

2.3

au/ml

19.8

22.2

0.31

763

(4035726)

970

9500

1.02

0.23

1.4

—

(3050380) Cytology report of Cervical or vaginal smear or scraping Cyto stain

938

9187

1.02

0.22

1.5

—

(21494429) FMR1 gene CGG repeat analysis in Blood or Tissue by Molecular genetics method

106

1.22

0.22

1.0

—

(3051101) Glucose [Moles/volume] in Cord blood

106

1.22

0.22

6.5

4.4

—

(3046896) Herpes virus 6 DNA [Presence] in Cerebral spinal fluid by NAA with probe detection

389

1.10

0.22

1.1

—

(21493195) Respiratory pathogens DNA and RNA tested for in Respiratory system specimen by NAA with probe detection

378

0.90

0.22

1.5

1.9

—

(3000764) Benzodiazepines [Presence] in Urine

777

7598

1.02

0.22

2.8

1.9

—

(3018980) carBAMazepine [Moles/volume] in Serum or Plasma

390

1.10

0.21

3.1

2.9

umol/l

27.1

27.9

0.20

301

(3032995) BK virus DNA [#/volume] (viral load) in Cerebral spinal fluid by NAA with probe detection

0.00

0.21

0.0

1.1

—

(3016976) Cortisol [Moles/volume] in Serum or Plasma --baseline

0.00

0.21

0.0

1.0

—

295.0

—

(3009992) Blasts/100 cells in Bone marrow

0.00

0.21

0.0

2.2

—

17.0

—

(3025566) Toxoplasma gondii IgG Ab [Units/volume] in Cerebral spinal fluid

0.00

0.21

0.0

1.0

—

(3022577) Toxoplasma gondii IgM Ab [Presence] in Cerebral spinal fluid

0.00

0.21

0.0

1.0

—

(3003191) Choriogonadotropin (pregnancy test) [Presence] in Serum or Plasma

870

8833

0.98

0.21

1.8

1.7

—

(3020047) Haemophilus influenzae B Ab [Mass/volume] in Serum

0.00

0.21

0.0

1.3

—

(3044316) Mercury [Moles/volume] in Urine

0.00

0.21

0.0

1.3

—

6.4

—

(3046594) Interleukin 8 [Mass/volume] in Serum or Plasma

0.00

0.21

0.0

1.5

—

11.1

—

(3001405) CD3+CD8+ (T8 suppressor) cells [#/volume] in Blood

921

0.94

0.20

2.5

e6/l

565.7

507.5

0.58

759

(3013924) Clostridium tetani IgG Ab [Units/volume] in Serum

173

1.15

0.20

1.3

1.1

—

(3050794) Legionella sp Ab [Presence] in Serum

1.25

0.20

1.1

1.2

—

(3008691) Amylase [Enzymatic activity/volume] in Peritoneal fluid

1.22

0.20

1.2

1.3

u/l

24.5

606.6

—

(3043453) Neutrophil cytoplasmic Ab.perinuclear [Titer] in Serum

961

0.94

0.19

1.2

titre

256.3

166.6

0.40

177

(3020059) Calcium [Moles/volume] corrected for albumin in Serum or Plasma

1855

18301

1.01

0.19

2.3

2.5

mmol/l

2.4

0.28

1620

15968

(3023919) Lactate dehydrogenase 2/Lactate dehydrogenase.total in Serum or Plasma by Electrophoresis

1.17

0.19

1.0

1.1

30.3

36.3

—

(3014037) CD3+CD4+ (T4 helper) cells/100 cells in Blood

567

1.07

0.19

3.1

2.7

46.0

44.2

0.27

212

(3028300) Cannabinoids [Presence] in Urine

781

7656

1.02

0.19

2.8

1.9

—

(3008092) Baker's yeast IgG Ab [Units/volume] in Serum

1.22

0.18

1.0

1.1

—

24.7

—

(4212803)

1.13

0.18

1.0

—

(3009347) Lactate dehydrogenase isoenzymes [Interpretation] in Serum or Plasma

1.13

0.18

1.0

1.1

—

(3029493) Herpes virus 6 DNA [Presence] in Blood by NAA with probe detection

1.13

0.18

1.2

1.3

—

(42869593) Oxyhemoglobin/Hemoglobin.total [Pure mass fraction] in Capillary blood

118

1.18

0.18

2.4

2.3

—

(42528717) Cashew nut recombinant (rAna o) 3 IgE Ab [Units/volume] in Serum

184

1.14

0.18

1.0

u/ml

0.0

0.3

0.86

137

(40768804) Tissue Pathology biopsy report

5563

55758

0.99

0.18

2.0

—

(3001556) Androgen free Index in Serum or Plasma

237

0.88

0.18

1.0

—

(3016881) Enterovirus RNA [Presence] in Specimen by NAA with probe detection

106

1006

1.05

0.18

1.4

1.6

—

(3036535) Thyroglobulin [Mass/volume] in Serum or Plasma

988

0.95

0.18

5.2

6.4

—

(3002067) Lambda light chains [Mass/time] in 24 hour Urine

1.21

0.17

1.6

3.2

—

(3025941) Bacteria identified in Stool by Culture

873

8578

1.02

0.17

1.3

1.2

—

(3006804) Neuronal Ab [Presence] in Cerebral spinal fluid

0.76

0.17

1.2

1.0

—

(3009677) Dengue virus Ab [Presence] in Serum

1.17

0.16

1.0

1.1

—

(3005011) Chlamydia sp Ab [Titer] in Serum

224

1.11

0.16

1.5

1.6

—

(3009595) Pneumocystis jiroveci DNA [Presence] in Specimen by NAA with probe detection

552

1.07

0.16

1.7

—

(3003327) Ova and parasites identified in Stool by Light microscopy

553

5617

0.98

0.16

1.7

—

(42868414) European tick borne encephalitis virus IgM Ab [Presence] in Serum by Immunoassay

452

0.93

0.16

1.2

1.1

—

(3027570) Oxalate [Moles/time] in 24 hour Urine

1.12

0.16

1.8

1.6

umol/24h

258.5

303.2

—

(3041672) Baker's yeast Ab [Presence] in Serum

1.12

0.16

1.0

—

(3027944) Amphetamines [Presence] in Urine

766

7526

1.02

0.15

2.6

1.9

—

(3002621) Streptococcal DNAse B [Units/volume] in Serum

0.77

0.15

1.0

1.1

—

(40769539) Bacteria identified based on 16S rRNA gene [Identifier] in Specimen by Sequencing

150

1443

1.04

0.15

1.7

1.5

—

(21494814) CD8 cells/100 lymphocytes in Specimen

471

0.93

0.15

1.9

2.1

—

(3014973) Borrelia burgdorferi IgM Ab [Units/volume] in Cerebral spinal fluid

165

1591

1.03

0.15

1.1

—

30.1

—

(43055225) Phosphorylated tau 181 [Mass/volume] in Cerebral spinal fluid by Immunoassay

440

0.93

0.15

1.0

ng/l

42.7

42.0

0.04

316

(3033386) Bacteria [Presence] in Cerebral spinal fluid by Light microscopy

614

0.94

0.15

1.4

1.6

—

(3027008) Opiates [Presence] in Urine

777

7640

1.02

0.15

2.7

1.9

—

(3023199) Leukocytes [#/volume] in Pleural fluid

542

0.94

0.14

1.6

1.4

e6/l

1694.3

3211.9

1.02

382

(40768443) Skin Pathology biopsy report

521

5107

1.02

0.14

1.2

—

(3027974) Hepatitis B virus e Ag [Presence] in Serum

0.81

0.14

1.0

1.5

—

(3013293) Extractable nuclear Ab [Presence] in Serum

274

1.09

0.14

1.6

1.7

—

(40759883) Oligoclonal Bands IgG [Presence] in Cerebral spinal fluid by Isoelectric focusing

142

1367

1.04

0.14

1.1

—

(40761872) Peanut recombinant (rAra h) 2 IgE Ab [Units/volume] in Serum

336

0.92

0.14

1.1

u/ml

0.1

0.8

1.56

232

(3049539) Genetic diseases [Identifier] in Blood or Tissue by FISH Nominal

731

1.05

0.14

1.2

—

(40758558) Short blood count panel - Blood

3052

30622

0.99

0.14

5.7

6.3

—

(3020393) Adenovirus Ag [Presence] in Stool

0.82

0.13

1.0

—

(3027831) CD3-CD16+CD56+ (Natural killer) cells/100 cells in Blood

988

0.96

0.13

2.1

2.0

12.4

13.1

0.24

497

(3014038) Collagen crosslinked N-telopeptide [Moles/volume] in Urine

180

0.89

0.13

1.7

1.5

—

(3022058) Hepatitis B virus DNA [Presence] in Serum or Plasma by NAA with probe detection

237

1.09

0.13

1.1

1.2

—

(3042810) Amyloid beta 42 peptide [Mass/volume] in Cerebral spinal fluid

437

0.94

0.13

1.0

ng/l

711.5

762.0

0.31

315

(3029715) Chromosome analysis.interphase [Interpretation] in Bone marrow by FISH Narrative

110

0.82

0.13

1.0

1.3

—

(3011412) CD3 cells [#/volume] in Blood

119

1229

0.97

0.12

2.4

e9/l

1.4

1.3

0.67

720

(3049717) Cytology report of Urine Cyto stain

200

1943

1.03

0.12

2.0

2.1

—

(3039355) Methicillin resistant Staphylococcus aureus [Presence] in Nose by Organism specific culture

113

1.15

0.12

1.9

1.8

—

(3009871) Measles virus Ab [Titer] in Serum

538

0.95

0.12

1.8

1.7

—

(3005411) Squamous cell carcinoma Ag [Mass/volume] in Serum or Plasma

323

0.93

0.12

1.4

2.1

ug/l

8.7

2.4

0.40

198

(43534046) Estradiol (E2) [Moles/volume] in Serum or Plasma by High sensitivity method

292

0.92

0.12

1.2

nmol/l

0.5

0.3

0.38

198

(3010503) CD19 cells [#/volume] in Blood

710

0.95

0.12

2.4

2.6

e9/l

0.1

0.4

1.52

699

(3001684) Respiratory syncytial virus Ag [Presence] in Specimen

486

0.94

0.12

1.0

1.1

—

(40771527) Human papilloma virus E6+E7 mRNA [Presence] in Cervix by NAA with probe detection

114

1175

0.97

0.11

2.1

1.9

—

(1001833) Epstein Barr virus DNA [Units/volume] (viral load) in Blood by NAA with probe detection

157

0.89

0.11

1.1

1.2

—

(40761849) Varicella zoster virus IgG Ab [Units/volume] in Cerebral spinal fluid by Immunoassay

278

1.08

0.11

1.1

—

(3014599) Egg white IgE Ab [Units/volume] in Serum

116

1194

0.97

0.11

1.1

1.0

u/ml

0.6

2.6

1.52

262

(3044936) Clostridioides difficile toxin A+B [Presence] in Stool by Immunoassay

239

0.92

0.11

1.0

1.2

—

(3002148) Methylenedioxymethamphetamine [Presence] in Urine by Screen method

112

1083

1.03

0.10

1.9

1.7

—

(3004915) Chlamydophila pneumoniae IgA Ab [Units/volume] in Serum

126

1221

1.03

0.10

1.1

—

(42529215) Follitropin [Units/volume] in Serum or Plasma by Immunoassay

430

4350

0.99

0.10

1.3

1.4

u/l

22.3

25.6

1.52

359

3578

(3025059) Transferrin.carbohydrate deficient [Mass/volume] in Serum or Plasma

125

1.12

0.09

1.0

1.1

mg/l

46.9

43.8

—

(40758047) Lysozyme [Mass/volume] in Pleural fluid

1.08

0.09

1.0

1.1

mg/l

29.6

13.3

—

(3016888) Borrelia burgdorferi IgG Ab [Units/volume] in Serum

917

9224

0.99

0.09

1.3

au/ml

40.0

40.6

0.03

366

(3014373) Corynebacterium diphtheriae Ab [Units/volume] in Serum

135

1.11

0.09

1.3

1.1

—

(3012741) Chlamydophila pneumoniae IgA Ab [Titer] in Serum

134

0.89

0.09

1.1

—

(3025547) Thyroglobulin Ab [Units/volume] in Serum or Plasma

171

1669

1.02

0.09

3.3

4.4

u/ml

94.9

119.0

0.25

527

(21493690) Lymphocyte T-cell and B-cell and Natural killer subsets panel - Blood

926

0.97

0.09

2.2

2.1

—

(3033319) Streptococcus pyogenes Ag [Presence] in Throat

2079

20840

0.99

0.09

1.4

—

(3024474) Albumin [Mass/volume] in Cerebral spinal fluid

143

1393

1.02

0.09

1.2

1.1

mg/l

199.5

207.8

0.49

128

1219

(3025927) Herpes simplex virus IgG Ab [Units/volume] in Cerebral spinal fluid by Immunoassay

126

1.11

0.08

1.1

—

(3041870) Hepatitis C virus IgG Ab [Presence] in Serum or Plasma by Immunoassay

195

0.92

0.08

1.4

1.1

—

(3052592) Norovirus Ag [Presence] in Stool

164

0.91

0.08

1.1

1.2

—

(3003434) Protein [Mass/volume] in Pleural fluid

580

0.96

0.08

1.8

1.4

g/l

32.8

35.5

0.73

537

(3020123) Porphyrins [Interpretation] in Serum or Plasma

1.13

0.07

1.1

—

(3017446) Testosterone [Moles/volume] in Serum or Plasma

209

2120

0.98

0.07

1.3

nmol/l

1.2

1.4

1.70

171

1757

(40758358) Immune stain study

0.84

0.07

1.0

—

(3018851) Theophylline [Moles/volume] in Serum or Plasma

0.83

0.07

1.7

2.2

umol/l

59.5

44.5

—

(3051339) Copper [Moles/volume] in Blood

0.81

0.07

1.5

1.4

umol/l

16.9

17.3

—

(3007695) Herpes simplex virus 2 IgG Ab [Presence] in Cerebral spinal fluid

153

0.91

0.07

1.1

—

(3025023) Rhinovirus RNA [Presence] in Specimen by NAA with probe detection

893

1.03

0.07

1.4

1.6

—

(3035400) Alkaline phosphatase.liver [Enzymatic activity/volume] in Serum or Plasma

696

1.03

0.07

1.3

1.2

u/l

72.9

83.3

0.98

621

(3013945) Hepatitis B virus e Ab [Presence] in Serum

0.86

0.07

1.0

1.4

—

(42869858) Acute and chronic leukemia fusion transcript panel - Blood or Tissue by Molecular genetics method

0.85

0.07

1.1

1.0

—

(43533860) Galactose-alpha-1,3-galactose (Alpha-Gal) IgE Ab [Units/volume] in Serum

285

0.94

0.07

1.1

u/ml

0.0

0.65

169

(3044941) Cell count panel - Synovial fluid

144

1409

1.02

0.06

1.4

—

(3023487) Leukocytes [#/volume] in Peritoneal fluid

254

0.94

0.06

1.8

2.1

e6/l

395.0

873.6

1.51

159

(3017962) TCRG gene rearrangements [Presence] in Blood or Tissue by Molecular genetics method

0.84

0.06

1.3

—

(40761871) Peanut recombinant (rAra h) 3 IgE Ab [Units/volume] in Serum

196

1.07

0.06

1.0

u/ml

0.0

0.04

106

(3012158) Parainfluenza virus 2 RNA [Presence] in Specimen by NAA with probe detection

481

1.04

0.06

1.4

1.8

—

(3025634) Parainfluenza virus 1 RNA [Presence] in Specimen by NAA with probe detection

481

1.04

0.06

1.4

1.8

—

(3006262) Parainfluenza virus 3 RNA [Presence] in Specimen by NAA with probe detection

481

1.04

0.06

1.4

1.8

—

(42868418) European tick borne encephalitis virus IgG Ab [Presence] in Cerebral spinal fluid by Immunoassay

101

0.89

0.06

1.2

1.1

—

(3015479) Mycobacterium sp identified in Blood by Organism specific culture

102

0.88

0.06

1.1

1.8

—

(3038177) Helicobacter pylori Ab [Presence] in Serum

284

2800

1.01

0.06

1.2

1.1

—

(3038297) Parainfluenza virus 4 RNA [Presence] in Specimen by NAA with probe detection

482

1.03

0.06

1.4

1.8

—

(3010380) Borrelia burgdorferi IgG Ab [Units/volume] in Cerebral spinal fluid

162

1590

1.02

0.06

1.1

—

62.6

—

(40761873) Peanut recombinant (rAra h) 1 IgE Ab [Units/volume] in Serum

202

0.94

0.06

1.0

u/ml

0.2

0.1

—

107

(40766183) Gliadin peptide IgA Ab [Units/volume] in Serum by Immunoassay

274

2763

0.99

0.05

1.1

u/ml

4.1

2.7

0.54

123

1500

(36305790) Ustekinumab [Mass/volume] in Serum or Plasma by Immunoassay

110

0.91

0.05

2.4

2.0

mg/l

3.9

3.2

—

105

(3011166) Borrelia burgdorferi Ab [Presence] in Cerebral spinal fluid

150

1473

1.02

0.05

1.1

—

(3023419) Bacteria identified in Sputum by Culture

947

0.98

0.05

2.3

2.6

—

(3037692) Legionella sp identified in Specimen by Organism specific culture

286

1.05

0.05

1.5

1.4

—

(40765089) Chromosome analysis panel - Blood by G-banded

595

0.97

0.05

1.0

—

(3012110) Lysozyme [Mass/volume] in Serum or Plasma

336

3320

1.01

0.05

2.1

2.2

mg/l

10.6

10.2

0.36

315

3115

(3043405) Microscopic observation [Identifier] in Specimen by Non-gynecological cytology method

104

1057

0.98

0.05

1.2

1.3

—

(40760007) HIV 1+2 Ab+HIV1 p24 Ag [Presence] in Serum or Plasma by Immunoassay

191

0.94

0.05

1.4

1.1

—

(3000242) Tau protein [Mass/volume] in Cerebral spinal fluid

433

0.97

0.05

1.0

ng/l

1191.6

333.0

0.51

318

(3044007) Cell count panel - Peritoneal fluid

208

1.05

0.05

1.8

2.1

—

(42529188) 25-Hydroxyvitamin D3+25-Hydroxyvitamin D2 [Moles/volume] in Serum or Plasma by Immunoassay

150

0.93

0.04

2.6

1.1

—

(3047166) Epithelial cells [#/area] in Urine sediment by Automated count

140

1.07

0.04

2.1

u/field

0.9

0.01

140

(3007368) IgG [Mass/volume] in Cerebral spinal fluid

145

1428

1.01

0.04

1.2

1.1

mg/l

33.8

36.4

0.36

120

1194

(3031072) Herpes simplex virus 1 IgG Ab [Presence] in Cerebral spinal fluid

149

0.94

0.03

1.1

—

(3028308) Erythrocytes [#/volume] in Pleural fluid

481

0.97

0.03

1.6

1.4

e6/l

168346.4

44723.9

0.52

261

(3025149) Bordetella pertussis IgA Ab [Units/volume] in Serum

114

1122

1.01

0.03

1.1

iu/ml

9.8

8.2

0.28

318

(3016417) Amylase.pancreatic [Enzymatic activity/volume] in Serum or Plasma

1076

10699

1.00

0.03

2.5

2.3

u/l

42.1

36.5

0.55

893

9152

(3043525) Herpes simplex virus Ab [Presence] in Cerebral spinal fluid

141

1.06

0.03

1.1

—

(1175426) CD3 cells/100 lymphocytes in Blood

1001

0.99

0.03

2.1

76.9

75.2

0.84

963

(3009613) Erythrocytes [#/volume] in Peritoneal fluid

228

0.96

0.02

1.6

1.9

e6/l

3134.4

16080.3

0.70

105

(3051651) Icteric interference index of Serum or Plasma

578

1.02

0.02

3.3

3.2

—

(42868417) European tick borne encephalitis virus IgG Ab [Presence] in Serum by Immunoassay

231

1.04

0.02

1.3

1.1

—

(42870325) Hepcidin 25 amino acid peptide [Moles/volume] in Serum or Plasma

182

1.04

0.02

1.3

1.7

nmol/l

392310.0

373208.8

0.02

153

(3002619) Bacteria identified in Specimen by Culture

237

0.97

0.01

1.1

1.2

—

(3024891) Influenza virus A+B Ag [Presence] in Specimen

362

3597

1.00

0.01

1.1

—

(3007798) IgG/Albumin [Mass Ratio] in Cerebral spinal fluid

427

0.98

0.01

1.1

—

(3009214) Lutropin [Units/volume] in Serum or Plasma

518

5152

1.00

0.01

1.2

u/l

11.3

12.3

0.98

437

4291

(3016031) Almond IgE Ab [Units/volume] in Serum

143

1.05

0.01

1.1

1.0

u/ml

0.7

0.3

—

(3004446) Plasmodium sp identified in Blood by Light microscopy

193

1.03

0.01

2.2

2.6

—

(3029511) Human papilloma virus DNA [Presence] in Specimen by NAA with probe detection

896

8947

1.00

0.01

1.5

—

(3045684) Alkaline phosphatase.other fractions [Enzymatic activity/volume] in Serum or Plasma

682

1.01

0.00

1.3

1.2

u/l

15.1

19.7

0.96

592

(3036071) Salmonella sp Ab [Titer] in Serum

483

1.01

0.00

1.1

—

(3027955) HFE gene mutations tested for in Blood or Tissue by Molecular genetics method Nominal

164

1.03

0.00

1.0

—

(3022475) Manganese [Moles/volume] in Blood

115

1.04

0.00

1.3

1.2

—

(3004905) Lipase [Enzymatic activity/volume] in Serum or Plasma

185

1.02

0.00

2.2

4.9

u/l

37.3

46.1

—

(3024869) Neuronal Ab [Presence] in Serum

155

0.97

0.00

1.1

1.0

—

(3037677) Mycoplasma pneumoniae IgM Ab [Titer] in Cerebral spinal fluid

296

1.01

0.00

1.1

—

(3005880) Parainfluenza virus 3 Ag [Presence] in Specimen

314

0.98

0.00

1.0

1.1

—

(3010464) Parainfluenza virus 1 Ag [Presence] in Specimen

314

0.98

0.00

1.0

1.1

—

(3021578) Parainfluenza virus 2 Ag [Presence] in Specimen

314

0.98

0.00

1.0

1.1

—

(3012320) Pathologist interpretation of Cerebral spinal fluid tests

229

1.00

0.00

1.1

1.2

—

(3009804) Carcinoembryonic Ag [Mass/volume] in Pleural fluid

1.05

0.00

1.1

ug/l

1.6

219.5

—

(3028009) Chlamydia trachomatis IgG Ab [Units/volume] in Serum

273

0.99

0.00

1.0

—

(3026051) Polymorphonuclear cells/100 leukocytes in Pleural fluid

116

1.03

0.00

1.4

1.5

15.9

21.1

0.53

101

(3000060) B lymphocytes [#/volume] in Blood

427

1.00

0.00

2.0

e6/l

201.1

172.4

0.24

230

(3033799) Differential panel - Peritoneal fluid

225

1.02

0.00

1.6

1.9

—

(3028717) Thiamine [Mass/volume] in Blood

153

0.98

0.00

1.2

—

(3006695) Toxoplasma gondii DNA [Presence] in Specimen by NAA with probe detection

153

0.98

0.00

2.2

1.7

—

(3026048) Bordetella pertussis IgG Ab [Units/volume] in Serum

325

1.01

0.00

1.1

—

(3035929) Mycoplasma pneumoniae Ab [Units/volume] in Cerebral spinal fluid

117

1.02

0.00

1.1

—

(3030313) Adrenal Ab [Titer] in Serum

224

0.98

0.00

1.2

1.0

—

(3035933) Granulocytes/100 leukocytes in Blood

446

1.01

0.00

2.8

1.7

—

(3036670) Protein [Mass/volume] in Synovial fluid

228

1.01

0.00

1.1

1.3

g/l

36.8

38.7

0.20

114

(1002224) Polysomnography panel

604

6023

1.00

0.00

1.1

—

(3002823) Mycoplasma pneumoniae IgG Ab [Units/volume] in Cerebral spinal fluid

294

1.02

0.00

1.1

—

(3017569) Oxygen content in Arterial blood

294

1.02

0.00

1.9

2.0

—

(3035880) pH of Pleural fluid

232

0.99

0.00

1.5

1.2

—

(3002256) Pathology report gross observation

1678

16739

1.00

0.00

1.2

—

(3005685) Amylase.salivary [Enzymatic activity/volume] in Serum or Plasma

0.89

0.00

1.0

1.1

u/l

32.2

53.6

—

(3017501) Neutrophils [#/volume] in Blood by Manual count

0.00

0.0

1.6

—

(3005812) Immunoglobulin light chains [Presence] in 24 hour Urine

0.96

0.00

1.2

2.1

—

(3027401) Testosterone Free/Testosterone.total in Serum or Plasma

0.00

0.0

1.0

—

1.1

—

(40763629) HC gene rearrangements [Presence] in Bone marrow by Molecular genetics method

0.00

0.0

1.0

—

(3015694) Chlamydophila pneumoniae IgG Ab [Titer] in Cerebral spinal fluid

0.00

0.0

1.0

—

(3009876) Amylase isoenzyme 3 panel - Serum or Plasma

0.95

0.00

1.0

1.2

—

(3031067) HIV 1 p24 Ag [Mass/volume] in Serum or Plasma by Immunoassay

1.00

0.00

1.0

—

(3042628) Porphyrins [Moles/volume] in Urine

0.00

0.0

1.0

—

(42868452) t(9;22)(q34.1;q11)(ABL1,BCR) e1a2 fusion transcript/control transcript [# Ratio] in Bone marrow by Molecular genetics method

0.00

0.0

2.6

—

(3006498) Trichoderma viride IgE Ab [Units/volume] in Serum

0.00

0.0

1.0

—

(3008896) Cortisol [Moles/volume] in Urine

0.00

0.0

1.4

—

(3017074) Chlamydophila pneumoniae IgM Ab [Titer] in Cerebral spinal fluid

0.00

0.0

1.0

—

(3033463) Neutrophils [#/volume] in Cerebral spinal fluid

0.00

0.0

1.0

—

(21494671) JAK2 gene exon 14 targeted mutation analysis in Bone marrow by Molecular genetics method

0.00

0.0

1.0

—

(3018688) Ampicillin IgE Ab [Units/volume] in Serum

1.01

0.00

1.0

—

(3044291) Thermoactinomyces vulgaris IgG Ab [Mass/volume] in Serum

0.00

0.0

1.0

—

(43055189) Lymphocytes [#/area] in Urine sediment by Microscopy high power field

0.00

0.0

1.0

—

(3013851) Stachybotrys chartarum IgE Ab [Units/volume] in Serum

0.00

0.0

1.0

—

(3020893) t(14;18)(q32;q21.3)(IGH,BCL2) fusion transcript [Presence] in Blood or Tissue by Molecular genetics method

0.00

0.0

1.0

—

(3003095) Rheumatoid factor [Units/volume] in Synovial fluid

0.00

0.0

1.0

—

Mortality – FinRegistry

↥

Association

Association between endpoint O15_PREEC_OR_FETGRO and mortality.

Females

Parameter	HR [95% CI]	p-value
O15_PREEC_OR_FETGRO	0.837 [0.72, 0.97]	0.017
Birth year	0.999 [0.99, 1.01]	0.864

During the follow-up period (1.1.1998 — 31.12.2019), 408 out of 58076 females with O15_PREEC_OR_FETGRO died.

Males

No data

Mortality risk

Mortality risk for people of age

years, who have O15_PREEC_OR_FETGRO.

N-year risk	Females	Males
1	0.074%	No data
5	0.497%	No data
10	1.248%	No data
15	2.567%	No data
20	4.479%	No data

Relationships between endpoints

↥

Index endpoint: O15_PREEC_OR_FETGRO – Pre-eclampsia or poor fetal growth

GWS hits: 6

Endpoint

Case Overlap

Survival Analysis

Genetic Correlations

Genetic Signals

N (Jaccard index)

HR [CI]

Extremity

rg [CI]

Extremity

Hits

Coloc Hits

FinRegistry

FinnGen

FinRegistry

FinnGen

Loading data

Pre-eclampsia or poor fetal growth

Endpoint definition

Endpoint definition steps

FinnGen

Phenotype data

1. Apply sex-specific rule

2. Check conditions

3. Check pre-conditions, main-only, mode, registry filters

4. Check minimum number of events

5. Include endpoints

6. Filter based on genotype QC (FinnGen only)

Similar endpoints

Case counts by codes

Summary Statistics

-FinRegistry-

Key figures

-FinnGen-

Key figures

-FinRegistry-

Age distribution of first events

-FinnGen-

Age distribution of first events

-FinRegistry-

Year distribution of first events

-FinnGen-

Year distribution of first events

-FinRegistry-

Cumulative Incidence Function

-FinnGen-

Cumulative Incidence Function

CodeWAS (R11)

Matched cohort

LabWAS

Mortality – FinRegistry

Association

Females

Males

Mortality risk

Relationships between endpoints